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Foreword 
 
The evaluation of research and doctoral training is being carried out in the years 2010–2012 and will end in 
2012. The steering group appointed by the Rector in January 2010 set the conditions for participating in 
the evaluation and prepared the Terms of Reference to present the evaluation procedure and criteria. The 
publications and other scientific activities included in the evaluation covered the years 2005–2010. 
The participating unit in the evaluation was defined as a Researcher Community (RC). To obtain a 
critical mass with university-level impact, the number of members was set to range from 20 to 120. The 
RCs were required to contain researchers in all stages of their research career, from doctoral students to 
principal investigators (PIs). All in all, 136 Researcher Communities participated in this voluntary 
evaluation, 5857 persons in total, of whom 1131 were principal investigators. PIs were allowed to 
participate in two communities in certain cases, and 72 of them used this opportunity and participated in 
two RCs. 
This evaluation enabled researchers to define RCs from the “bottom up” and across disciplines. The aim 
of the evaluation was not to assess individual performance but a community with shared aims and 
researcher-training activities. The RCs were able to choose among five different categories that 
characterised the status and main aims of their research. The steering group considered the process of 
applying to participate in the evaluation to be important, which lead to the establishment of these 
categories. In addition, providing a service for the RCs to enable them to benchmark their research at the 
global level was a main goal of the evaluation. 
The data for the evaluation consisted of the RCs’ answers to evaluation questions on supplied e-forms 
and a compilation extracted from the TUHAT – Research Information System (RIS) on 12 April 2011. The 
compilation covered scientific and other publications as well as certain areas of scientific activities. During 
the process, the RCs were asked to check the list of publications and other scientific activities and make 
corrections if needed. These TUHAT compilations are public and available on the evaluation project sites 
of each RC in the TUHAT-RIS. 
In addition to the e-form and TUHAT compilation, University of Leiden (CWTS) carried out bibliometric 
analyses from the articles included in the Web of Science (WoS). This was done on University and RC 
levels. In cases where the publication forums of the RC were clearly not represented by the WoS data, the 
Library of the University of Helsinki conducted a separate analysis of the publications. This was done for 
66 RCs representing the humanities and social sciences. 
The evaluation office also carried out an enquiry targeted to the supervisors and PhD candidates about 
the organisation of doctoral studies at the University of Helsinki. This and other documents describing the 
University and the Finnish higher education system were provided to the panellists. 
The panel feedback for each RC is unique and presented as an entity. The first collective evaluation 
reports available for the whole panel were prepared in July–August 2011. The reports were accessible to all 
panel members via the electronic evaluation platform in August. Scoring from 1 to 5 was used to 
complement written feedback in association with evaluation questions 1–4 (scientific focus and quality, 
doctoral training, societal impact, cooperation) and in addition to the category evaluating the fitness for 
participation in the evaluation. Panellists used the international level as a point of comparison in the 
evaluation. Scoring was not expected to go along with a preset deviation. 
Each of the draft reports were discussed and dealt with by the panel in meetings in Helsinki (from 11 
September to 13 September or from 18 September to 20 September 2011). In these meetings the panels 
also examined the deviations among the scores and finalised the draft reports together. 
The current RC-specific report deals shortly with the background of the evaluation and the terms of 
participation. The main evaluation feedback is provided in the evaluation report, organised according to 
the evaluation questions. The original material provided by the RCs for the panellists has been attached to 
these documents. 
 
 
 
 
 
 
 
 
 
On behalf of the evaluation steering group and office, I sincerely wish to thank you warmly for your 
participation in this evaluation. The effort you made in submitting the data to TUHAT-RIS is gratefully 
acknowledged by the University. We wish that you find this panel feedback useful in many ways. The 
bibliometric profiles may open a new view on your publication forums and provide a perspective for 
discussion on your choice of forums. We especially hope that this evaluation report will help you in setting 
the future goals of your research. 
 
Johanna Björkroth 
Vice-Rector 
Chair of the Steering Group of the Evaluation 
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Acronyms and abbreviations applied in the report 
 
External competitive funding 
AF – Academy of Finland 
TEKES - Finnish Funding Agency for Technology and Innovation  
EU - European Union 
ERC - European Research Council 
International and national foundations 
FP7/6 etc. /Framework Programmes/Funding of European Commission 
 
Evaluation marks 
Outstanding (5) 
Excellent  (4) 
Very Good  (3) 
Good  (2) 
Sufficient  (1) 
 
Abbreviations of Bibliometric Indicators 
P - Number of publications 
TCS – Total number of citations 
MCS - Number of citations per publication, excluding self-citations 
PNC - Percentage of uncited publications 
MNCS - Field-normalized number of citations per publication 
MNJS - Field-normalized average journal impact 
THCP10 - Field-normalized proportion highly cited publications (top 10%) 
INT_COV - Internal coverage, the average amount of references covered by the WoS 
WoS – Thomson Reuters Web of Science Databases 
 
Participation category 
Category 1. The research of the participating community represents the international cutting edge in its 
field. 
Category 2. The research of the participating community is of high quality, but the community in its 
present composition has yet to achieve strong international recognition or a clear break-through. 
Category 3. The research of the participating community is distinct from mainstream research, and the 
special features of the research tradition in the field must be considered in the evaluation. 
Category 4. The research of the participating community represents an innovative opening. 
Category 5. The research of the participating community has a highly significant societal impact. 
 
Research focus areas of the University of Helsinki 
Focus area 1: The basic structure, materials and natural resources of the physical world 
Focus area 2: The basic structure of life 
Focus area 3: The changing environment – clean water 
Focus area 4: The thinking and learning human being 
Focus area 5: Welfare and safety 
Focus area 6: Clinical research 
Focus area 7: Precise reasoning 
Focus area 8: Language and culture 
Focus area 9: Social justice 
Focus area 10: Globalisation and social change 
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1 Introduction to the Evaluation 
1.1 RC-specific evaluation reports 
The participants in the evaluation of research and doctoral training were Researcher Communities 
(hereafter referred to as the RC). The RC refers to the group of researchers who registered together in the 
evaluation of their research and doctoral training. Preconditions in forming RCs were stated in the 
Guidelines for the Participating Researcher Communities. The RCs defined themselves whether their 
compositions should be considered well-established or new. 
It is essential to emphasise that the evaluation combines both meta-evaluation1 and traditional 
research assessment exercise and its focus is both on the research outcomes and procedures associated 
with research and doctoral training. The approach to the evaluation is enhancement-led where self-
evaluation constituted the main information. The answers to the evaluation questions formed together 
with the information of publications and other scientific activities an entity that was to be reviewed as a 
whole. 
The present evaluation recognizes and justifies the diversity of research practices and publication 
traditions. Traditional Research Assessment Exercises do not necessarily value high quality research with 
low volumes or research distinct from mainstream research. It is challenging to expose the diversity of 
research to fair comparison. To understand the essence of different research practices and to do justice to 
their diversity was one of the main challenges of the present evaluation method. Understanding the 
divergent starting points of the RCs demanded sensitivity from the evaluators. 
1.2 Aims and objectives in the evaluation 
The aims of the evaluation are as follows: 
 to improve the level of research and doctoral training at the University of Helsinki and to raise 
their international profile in accordance with the University’s strategic policies. The improvement 
of doctoral training should be compared to the University’s policy.2 
 to enhance the research conducted at the University by taking into account the diversity, 
originality, multidisciplinary nature, success and field-specificity, 
 to recognize the conditions and prerequisites under which excellent, original and high-impact 
research is carried out, 
 to offer the academic community the opportunity to receive topical and versatile international 
peer feedback, 
 to better recognize the University’s research potential. 
 to exploit the University’s TUHAT research information system to enable transparency of 
publishing activities and in the production of reliable, comparable data. 
1.3 Evaluation method 
The evaluation can be considered as an enhancement-led evaluation. Instead of ranking, the main aim is to 
provide useful information for the enhancement of research and doctoral training of the participating RCs. 
The comparison should take into account each field of science and acknowledge their special character. 
                                                                
1 The panellists did not read research reports or abstracts but instead, they evaluated answers to the evaluation 
questions, tables and compilations of publications, other scientific activities, bibliometrics or comparable analyses. 
2
 Policies on doctoral degrees and other postgraduate degrees at the University of Helsinki.  
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The comparison produced information about the present status and factors that have lead to success. Also 
challenges in the operations and outcomes were recognized. 
The evaluation approach has been designed to recognize better the significance and specific nature of 
researcher communities and research areas in the multidisciplinary top-level university. Furthermore, one 
of the aims of the evaluation is to bring to light those evaluation aspects that differ from the prevalent 
ones. Thus the views of various fields of research can be described and research arising from various 
starting points understood better. The doctoral training is integrated into the evaluation as a natural 
component related to research. Operational processes of doctoral training are being examined in the 
evaluation. 
 
Five stages of the evaluation method were: 
1. Registration – Stage 1 
2. Self-evaluation – Stage 2 
3. TUHAT3 compilations on publications and other scientific activities4 
4. External evaluation 
5. Public reporting 
1.4 Implementation of the external evaluation 
Five Evaluation Panels 
Five evaluation panels consisted of independent, renowned and highly respected experts. The main 
domains of the panels are: 
1. biological, agricultural and veterinary sciences 
2. medicine, biomedicine and health sciences 
3. natural sciences 
4. humanities 
5. social sciences 
The University invited 10 renowned scientists to act as chairs or vice-chairs of the five panels based on 
the suggestions of faculties and independent institutes. Besides leading the work of the panel, an 
additional role of the chairs was to discuss with other panel chairs in order to adopt a broadly similar 
approach. The panel chairs and vice-chairs had a pre-meeting on 27 May 2011 in Amsterdam. 
The panel compositions were nominated by the Rector of the University 27 April 2011. The participating 
RCs suggested the panel members. The total number of panel members was 50. The reason for a smaller 
number of panellists as compared to the previous evaluations was the character of the evaluation as a 
meta-evaluation. The panellists did not read research reports or abstracts but instead, they evaluated 
answers to the evaluation questions, tables and compilations of publications, other scientific activities, 
bibliometrics and comparable analyses. 
 
The panel meetings were held in Helsinki: 
 On 11–13 September 2011: (1) biological, agricultural and veterinary sciences, (2) medicine, 
biomedicine and health sciences and (3) natural sciences.  
 On 18–20 September 2011: (4) humanities and (5) social sciences. 
  
                                                                
3 TUHAT (acronym) of Research Information System (RIS) of the University of Helsinki 
4 Supervision of thesis, prizes and awards, editorial work and peer reviews, participation in committees, boards and 
networks and public appearances. 
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1.5 Evaluation material 
The main material in the evaluation was the RCs’ self-evaluations that were qualitative in character and 
allowed the RCs to choose what was important to mention or emphasise and what was left unmentioned. 
The present evaluation is exceptional at least in the Finnish context because it is based on both the 
evaluation documentation (self-evaluation questions, publications and other scientific activities) and the 
bibliometric reports. All documents were delivered to the panellists for examination. 
Traditional bibliometrics can be reasonably done mainly in medicine, biosciences and natural sciences 
when using the Web of Science database, for example. Bibliometrics, provided by CWTS/The Centre for 
Science and Technology Studies, University of Leiden, cover only the publications that include WoS 
identification in the TUHAT-RIS. 
Traditional bibliometrics are seldom relevant in humanities and social sciences because the 
international comparable databases do not store every type of high quality research publications, such as 
books and monographs and scientific journals in other languages than English. The Helsinki University 
Library has done analysis to the RCs, if their publications were not well represented in the Web of Science 
databases (RCs should have at least 50 publications and internal coverage of publications more than 40%) 
– it meant 58 RCs. The bibliometric material for the evaluation panels was available in June 2011. The RC-
specific bibliometric reports are attached at the end of each report. 
The panels were provided with the evaluation material and all other necessary background information, 
such as the basic information about the University of Helsinki and the Finnish higher education system. 
 
Evaluation material 
1. Registration documents of the RCs for the background information 
2. Self evaluation material – answers to the evaluation questions 
3. Publications and other scientific activities based on the TUHAT RIS: 
3.1. statistics of publications 
3.2. list of publications 
3.3. statistics of other scientific activities 
3.4. list of other scientific activities 
4. Bibliometrics and comparable analyses: 
4.1. Analyses of publications based on the verification of TUHAT-RIS publications with the Web 
of Science publications (CWTS/University of Leiden) 
4.2. Publication statistics analysed by the Helsinki University Library - mainly for humanities and 
social sciences 
5. University level survey on doctoral training (August 2011) 
6. University level analysis on publications 2005–2010 (August 2011) provided by CWTS/University 
of Leiden 
 
Background material 
 
University of Helsinki 
- Basic information about the University of the Helsinki 
- The structure of doctoral training at the University of Helsinki 
- Previous evaluations of research at the University of Helsinki – links to the reports: 1998 and 2005 
 
The Finnish Universities/Research Institutes 
- Finnish University system 
- Evaluation of the Finnish National Innovation System 
- The State and Quality of Scientific Research in Finland. Publication of the Academy of Finland 
9/09. 
 
The evaluation panels were provided also with other relevant material on request before the meetings in 
Helsinki. 
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1.6 Evaluation questions and material 
The participating RCs answered the following evaluation questions which are presented according to the 
evaluation form. In addition, TUHAT RIS was used to provide the additional material as explained. For 
giving the feedback to the RCs, the panellists received the evaluation feedback form constructed in line 
with the evaluation questions: 
 
1. Focus and quality of the RC’s research 
 Description of 
- the RC’s research focus. 
- the quality of the RC’s research (incl. key research questions and results) 
- the scientific significance of the RC’s research in the research field(s) 
 Identification of the ways to strengthen the focus and improve the quality of the RC’s research 
The additional material: TUHAT compilation of the RC’s publications, analysis of the RC’s publications data 
(provided by University of Leiden and the Helsinki University Library) 
A written feedback from the aspects of: scientific quality, scientific significance, societal impact, 
innovativeness 
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
Numeric evaluation: OUTSTANDING (5), EXCELLENT (4), VERY GOOD (3), GOOD (2), SUFFICIENT (1) 
 
2. Practises and quality of doctoral training 
 Organising of the doctoral training in the RC. Description of the RC’s principles for: 
- recruitment and selection of doctoral candidates 
- supervision of doctoral candidates 
- collaboration with faculties, departments/institutes, and potential graduate schools/doctoral 
programmes 
- good practises and quality assurance in doctoral training 
- assuring of good career perspectives for the doctoral candidates/fresh doctorates 
 Identification of the RC’s strengths and challenges related to the practises and quality of doctoral 
training, and the actions planned for their development. 
The additional material: TUHAT compilation of the RC’s other scientific activities/supervision of doctoral 
dissertations 
A written feedback from the aspects of: processes and good practices related to leadership and 
management 
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
Numeric evaluation: OUTSTANDING (5), EXCELLENT (4), VERY GOOD (3), GOOD (2), SUFFICIENT (1) 
 
3. The societal impact of research and doctoral training 
 Description on how the RC interacts with and contributes to the society (collaboration with 
public, private and/or 3rd sector). 
 Identification of the ways to strengthen the societal impact of the RC’s research and doctoral 
training. 
The additional material: TUHAT compilation of the RC’s other scientific activities. 
A written feedback from the aspects of: societal impact, national and international collaboration, 
innovativeness 
 
  Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
Numeric evaluation: OUTSTANDING (5), EXCELLENT (4), VERY GOOD (3), GOOD (2), SUFFICIENT (1) 
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4. International and national (incl. intersectoral) research collaboration and researcher mobility 
 Description of  
- the RC’s research collaborations and joint doctoral training activities 
- how the RC has promoted researcher mobility 
 Identification of the RC’s strengths and challenges related to research collaboration and 
researcher mobility, and the actions planned for their development. 
A written feedback from the aspects of: scientific quality, national and international collaboration 
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
Numeric evaluation: OUTSTANDING (5), EXCELLENT (4), VERY GOOD (3), GOOD (2), SUFFICIENT (1) 
 
5. Operational conditions  
 Description of the operational conditions in the RC’s research environment (e.g. research 
infrastructure, balance between research and teaching duties). 
 Identification of the RC’s strengths and challenges related to operational conditions, and the 
actions planned for their development. 
A written feedback from the aspects of: processes and good practices related to leadership and 
management 
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
6. Leadership and management in the researcher community 
 Description of 
- the execution and processes of leadership in the RC 
- how the management-related responsibilities and roles are distributed in the RC 
- how the leadership- and management-related processes support 
- high quality research 
- collaboration between principal investigators and other researchers in the RC 
the RC’s research focus 
- strengthening of the RC’s know-how 
 Identification of the RC’s strengths and challenges related to leadership and management, and 
the actions planned for developing the processes 
 
7. External competitive funding of the RC 
 The RCs were asked to provide information of such external competitive funding, where: 
- the funding decisions have been made during 1.1.2005-31.12.2010, and 
- the administrator of the funding is/has been the University of Helsinki 
 On the e-form the RCs were asked to provide: 
1) The relevant funding source(s) from a given list (Academy of Finland/Research Council, TEKES/The 
Finnish Funding Agency for Technology and Innovation , EU, ERC, foundations, other national funding 
organisations, other international funding organisations), and 
2)The total sum of funding which the organisation in question had decided to allocate to the RCs 
members during 1.1.2005–31.12.2010. 
 
Competitive funding reported in the text is also to be considered when evaluating this point. 
A written feedback from the aspects of: scientific quality, scientific significance, societal impact, 
innovativeness, future significance 
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
8. The RC’s strategic action plan for 2011–2013 
 RC’s description of their future perspectives in relation to research and doctoral training. 
A written feedback from the aspects of: scientific quality, scientific significance, societal Impact, processes 
and good practices related to leadership and management, national and international collaboration, 
innovativeness, future significance 
 Strengths 
 Areas of development 
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 Other remarks 
 Recommendations 
 
9. Evaluation of the category of the RC in the context of entity of the evaluation material (1-8) 
 
The RC’s fitness to the chosen participation category 
A written feedback evaluating the RC’s fitness to the chosen participation category  
 Strengths 
 Areas of development 
 Other remarks 
 Recommendations 
 
Numeric evaluation: OUTSTANDING (5), EXCELLENT (4), VERY GOOD (3), GOOD (2), SUFFICIENT (1) 
 
10. Short description of how the RC members contributed the compilation of the stage 2 material 
Comments on the compilation of evaluation material 
 
11. How the UH’s focus areas are presented in the RC’s research? 
Comments if applicable 
 
12. RC-specific main recommendations based on the previous questions 1–11 
 
13. RC-specific conclusions 
1.7 Evaluation criteria 
The panellists were expected to give evaluative and analytical feedback to each evaluation question 
according to their aspects in order to describe and justify the quality of the submitted material. In 
addition, the evaluation feedback was asked to be pointed out the level of the performance according to 
the following classifications: 
 outstanding  (5) 
 excellent  (4) 
 very good  (3) 
 good   (2) 
 sufficient  (1) 
 
Evaluation according to the criteria was to be made with thorough consideration of the entire 
evaluation material of the RC in question. Finally, in questions 1-4 and 9, the panellists were expected to 
classify their written feedback into one of the provided levels (the levels included respective descriptions, 
‘criteria’). Some panels used decimals in marks. The descriptive level was interpreted according to the 
integers and not rounding up the decimals by the editors. 
 
Description of criteria levels 
Question 1 – FOCUS AND QUALITY OF THE RC’S RESEARCH 
 
Classification: Criteria (level of procedures and results) 
Outstanding quality of procedures and results (5) 
Outstandingly strong research, also from international perspective. Attracts great international 
interest with a wide impact, including publications in leading journals and/or monographs published 
by leading international publishing houses. The research has world leading qualities. The research 
focus, key research questions scientific significance, societal impact and innovativeness are of 
outstanding quality. 
In cases where the research is of a national character and, in the judgement of the evaluators, should 
remain so, the concepts of ”international attention” or ”international impact” etc. in the grading 
criteria above may be replaced by ”international comparability”. 
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Operations and procedures are of outstanding quality, transparent and shared in the community. The 
improvement of research and other efforts are documented and operations and practices are in 
alignment with the documentation. The ambition to develop the community together is of 
outstanding quality. 
Excellent quality of procedures and results (4) 
Research of excellent quality. Typically published with great impact, also internationally. Without 
doubt, the research has a leading position in its field in Finland. 
Operations and procedures are of excellent quality, transparent and shared in the community. The 
improvement of research and other efforts are documented and operations and practices are to 
large extent in alignment with the documentation. The ambition to develop the community together 
is of excellent quality. 
Very good quality of procedures and results (3) 
The research is of such very good quality that it attracts wide national and international attention. 
Operations and procedures are of very good quality, transparent and shared in the community. The 
improvement of research and other efforts are documented and operations and practices are to 
large extent in alignment with the documentation. The ambition to develop the community together 
is of very good quality. 
Good quality of procedures and results (2) 
Good research attracting mainly national attention but possessing international potential, 
extraordinarily high relevance may motivate good research. 
Operations and procedures are of good quality, shared occasionally in the community. The 
improvement of research and other efforts are occasionally documented and operations and 
practices are to large extent in alignment with the documentation. The ambition to develop the 
community together is of good quality. 
Sufficient quality of procedures and results (1) 
In some cases the research is insufficient and reports do not gain wide circulation or do not have 
national or international attention. Research activities should be revised. 
Operations and procedures are of sufficient quality, shared occasionally in the community. The 
improvement of research and other efforts are occasionally documented and operations and 
practices are to some extent in alignment with the documentation. The ambition to develop the 
community together is of sufficient quality. 
 
Question 2 – DOCTORAL TRAINING 
Question 3 – SOCIETAL IMPACT 
Question 4 – COLLABORATION 
 
Classification: Criteria (level of procedures and results) 
Outstanding quality of procedures and results (5) 
Procedures are of outstanding quality, transparent and shared in the community. The practices and 
quality of doctoral training/societal impact/international and national collaboration/leadership and 
management are documented and operations and practices are in alignment with the 
documentation. The ambition to develop the community together is of outstanding quality. The 
procedures and results are regularly evaluated and the feedback has an effect on the planning. 
Excellent quality of procedures and results (4) 
Procedures are of excellent quality, transparent and shared in the community. The practices and 
quality of doctoral training/societal impact/international and national collaboration/leadership and 
management are documented and operations and practices are to large extent in alignment with the 
documentation. The ambition to develop the community together is of excellent quality. The 
procedures and outcomes are evaluated and the feedback has an effect on the planning. 
Very good quality of procedures and results (3) 
Procedures are of very good quality, transparent and shared in the community. The practices and 
quality of doctoral training/societal impact/international and national collaboration/leadership and 
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management are documented and operations and practices are to large extent in alignment with the 
documentation. The ambition to develop the community together is of very good quality. 
Good quality of procedures and results (2) 
Procedures are of good quality, shared occasionally in the community. The practices and quality of 
doctoral training/societal impact/international and national collaboration/leadership and 
management are documented and operations and practices are to large extent in alignment with the 
documentation. The ambition to develop the community together is of good quality. 
Sufficient quality of procedures and results (1) 
Procedures are of sufficient quality, transparent and shared in the community. The practices and 
quality of doctoral training/societal impact/international and national collaboration/leadership and 
management are occasionally documented and operations and practices are to some extent in 
alignment with the documentation. The ambition to develop the community together is of sufficient 
quality. 
 
Question 9 – CATEGORY 
Participation category – fitness for the category chosen 
The choice and justification for the chosen category below should be reflected in the RC’s responses to the 
evaluation questions 1–8. 
1. The research of the participating community represents the international cutting edge in its field. 
2. The research of the participating community is of high quality, but the community in its present 
composition has yet to achieve strong international recognition or a clear break-through. 
3. The research of the participating community is distinct from mainstream research, and the special 
features of the research tradition in the field must be considered in the evaluation. The research is 
of high quality and has great significance and impact in its field. However, the generally used 
research evaluation methods do not necessarily shed sufficient light on the merits of the 
research.  
4. The research of the participating community represents an innovative opening. A new opening can 
be an innovative combination of research fields, or it can be proven to have a special social, 
national or international demand or other significance. Even if the researcher community in its 
present composition has yet to obtain proof of international success, its members can produce 
convincing evidence of the high level of their previous research. 
5. The research of the participating community has a highly significant societal impact. The 
participating researcher community is able to justify the high social significance of its research. 
The research may relate to national legislation, media visibility or participation in social debate, 
or other activities promoting social development and human welfare. In addition to having 
societal impact, the research must be of a high standard. 
 
An example of outstanding fitness for category choice (5) 5 
The RC’s representation and argumentation for the chosen category were convincing. The RC recognized 
its real capacity and apparent outcomes in a wider context to the research communities. The specific 
character of the RC was well-recognized and well stated in the responses. The RC fitted optimally for the 
category. 
 
 Outstanding  (5) 
 Excellent  (4) 
 Very good  (3) 
 Good   (2) 
 Sufficient  (1) 
The above-mentioned definition of outstanding was only an example in order to assist the panellists in 
the positioning of the classification. There was no exact definition for the category fitness. 
                                                                
5 The panels discussed the category fitness and made the final conclusions of the interpretation of it. 
 
 
13 
 
1.8 Timetable of the evaluation 
The main timetable of the evaluation: 
1. Registration   November 2010 
2. Submission of self-evaluation materials  January–February 2011 
3. External peer review    May–September 2011 
4. Published reports    March–April 2012 
- University level public report 
- RC specific reports 
 
The entire evaluation was implemented during the university’s strategy period 2010–2012. The preliminary 
results were available for the planning of the following strategy period in late autumn 2011. The evaluation 
reports will be published in March/April 2012. More detailed time schedule is published in the University 
report. 
1.9 Evaluation feedback – consensus of the entire panel 
The panellists evaluated all the RC-specific material before the meetings in Helsinki and mailed the 
draft reports to the evaluation office. The latest interim versions were on-line available to all the panellists 
on the Wiki-sites. In September 2011, in Helsinki the panels discussed the material, revised the first draft 
reports and decided the final numeric evaluation. After the meetings in Helsinki, the panels continued 
working and finalised the reports before the end of November 2011. The final RC-specific reports are the 
consensus of the entire panel. 
The evaluation reports were written by the panels independently. During the editing process, the 
evaluation office requested some clarifications from the panels when necessary. The tone and style in the 
reports were not harmonized in the editing process. All the reports follow the original texts written by the 
panels as far as it was possible. 
The original evaluation material of the RCs, provided for the panellists is attached at the end of the 
report. It is essential to notice that the exported lists of publications and other scientific activities depend 
how the data was stored in the TUHAT-RIS by the RCs. 
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2 Evaluation feedback 
2.1 Focus and quality of the RC’s research 
 Description of 
 the RC’s research focus 
 the quality of the RC’s research (incl. key research questions and results) 
 the scientific significance of the RC’s research in the research field(s) 
 Identification of the ways to strengthen the focus and improve the quality of the RC’s research 
ASPECTS: Scientific quality, scientific significance, societal impact, innovativeness 
 
The Infection Biology (InfBio) programme is strong and composed of ten individual groups working with 
infection and immunity, bacteria and viruses. The RC is very strong in the Haartman Institute, and they 
have a common focus in the microbial virulence. The leading part of this RC is based on the work of the RC 
director Prof. Seppo Meri containing almost all the aspects of high quality work in the complement system 
with his team and followers like Docent Sakari Jokiranta. The virology is well represented by Profs. Antti 
Vaheri, Kalle Saksela, Klaus Hedman and molecular bacteriology is represented by Prof. Mikael Skurnik. All 
these teams make the critical mass to study various aspects of microbial diseases and how the innate 
immune system like complement reacts against the pathogens. Helsinki and Meilahti campus has a long 
tradition to foster virology at cutting-edge level in the world, and Antti Vaheri and his followers have kept 
excellent level both in basic virology and viral diagnostics and clinical applications. The RC has produced a 
lot of publications and PhDs and has an excellent external funding. The groups are complementary to each 
other and the basis for excellent programme is clear-cut, but the lack of a centre of excellence and the 
doctoral programme recognized by the Academy of Finland and the Ministry of Culture and Education 
lowers a little bit of their achievements. The RC has been active in doctoral training with excellent results. 
The really top notch articles in the highly competitive fields like immunology and virology are very few 
among 427 published articles. The RC should also have future young group leaders included in the RC as 
well as RC Lokki should be fused somehow to this consortium based on long term high quality and 
productive research done in the Meilahti area. Also the faculty borders should be crossed as in Viikki 
campus there is an outstanding virology programme headed by Dennis Bamford which would have 
additive value with the doctoral programme and the centre of excellence and doctoral programme to this 
infection biology programme. It is a great pity that Viikki and Meilahti are not close enough to cross the 
faculty borders. RC Meri programme is innovative and has a huge potential in translational medicine as 
shown by the complement and virology researchers but maybe there is a lack of basic research, done 
more in Viikki in structural virology than in Meilahti campus. 
Recommendations: 1) Fuse RC Lokki into your programme, 2) Tie the young promising group leaders 
like Dr Petteri Arstila into your programme, 3) Try to see the opportunities to cross the faculty borders and 
try to make a common programme with Viikki virologists to reach the cutting edge outstanding level. 
Numeric evaluation: 4 (Excellent) 
2.2 Practises and quality of doctoral training 
 Organising of the doctoral training in the RC. Description of the RC’s principles for: 
 recruitment and selection of doctoral candidates 
 supervision of doctoral candidates 
 collaboration with faculties, departments/institutes, and potential graduate schools/doctoral 
programmes 
 good practises and quality assurance in doctoral training 
 assuring of good career perspectives for the doctoral candidates/fresh doctorates 
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 Identification of the RC’s strengths and challenges related to the practises and quality of doctoral 
training, and the actions planned for their development. 
 Additional material: TUHAT compilation of the RC’s other scientific activities/supervision of doctoral 
dissertations 
ASPECTS: Processes and good practices related to leadership and management 
 
The RC has produced 64 doctoral theses under the evaluation period, which is an excellent achievement, 
and their processes and practises have been described in an excellent way, but they have not yet got the 
doctoral programme in infection biology recognized by the Academy of Finland and Ministery of Culture 
and Education. They have been very active in Helsinki Biomedical Doctoral Programme but their feelings 
are a little bit like outsiders compared with scientists working in Biomedicum and FIMM. Recommendation 
might be that the Meri RC should be more active in collaboration locally within Meilahti campus area but 
also with people from Viikki campus. Together with all the efforts and trying to combine all the 
researchers working with microbes and immune system at all the levels it would be a fortunate investment 
for the University of Helsinki to be recognized at the cutting edge level also globally. 
Numeric evaluation: 5 (Outstanding) 
2.3 The societal impact of research and doctoral training 
 Description on how the RC interacts with and contributes to the society (collaboration with public, 
private and/or 3rd sector). 
 Identification of the ways to strengthen the societal impact of the RC’s research and doctoral training. 
 Additional material: TUHAT compilation of the RC’s other scientific activities. 
ASPECTS: Societal impact, national and international collaboration, innovativeness 
 
The impact of their research has a huge value in current society still fighting against microbes and new 
emerging infectious diseases, and vaccination against new enemies is of prime importance. The 
diagnostics of the microbial diseases is also in the focus of this RC, and their applications have been very 
innovative and useful in clinical perspective. The RC has been collaborative with various clinical 
departments, and EVO funding has been an important part of their expenses. However, the basic research 
in microbial virulence and immune defence as such may have suffered against the more applicatory and 
clinical approaches. However, the RC has reached more mechanistic level in basic complement studies 
highlighted with structural analysis of various complement components like factor H in hemolytic uremia 
syndrome. 
Doctoral training has been very successful resulting into 66 PhDs during the evaluation period although 
the RC has not been directly funded by the Academy of Finland and Ministry of Culture and Education 
through doctoral programme funding. 
Recommendation: The RC should collaborate more with local doctoral programme in biomedical 
sciences in Biomedicum and FIMM, and see the possibilities to collaborate with Bamford group in Viikki 
heading the one of the excellent doctoral programmes in Finland. 
Numeric evaluation: 4 (Excellent) 
2.4 International and national (incl. intersectoral) research 
collaboration and researcher mobility 
 Description of  
 the RC’s research collaborations and joint doctoral training activities 
 how the RC has promoted researcher mobility 
 Identification of the RC’s strengths and challenges related to research collaboration and researcher 
mobility, and the actions planned for their development. 
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ASPECTS: Scientific quality, national and international collaboration 
 
The RC has been very active in EU-networks and also Erasmus and Marie Curie actions. International 
collaboration is extensive and clearly shows the strongness of the RC. The RC has obtained significant 
funding from EU and ERC. The director of the RC has been active also in a development project dealing 
with European PhD training. The RC has a long-term and successful collaboration with the National 
Institute of Health and Welfare (THL) in Helsinki area. 
Recommendation: Groups working in THL could also be a member in this programme like e.g. Prof. 
Ilkka Julkunen. 
Numeric evaluation: 4 (Excellent) 
2.5 Operational conditions 
 Description of the operational conditions in the RC’s research environment (e.g. research 
infrastructure, balance between research and teaching duties). 
 Identification of the RC’s strengths and challenges related to operational conditions, and the actions 
planned for their development. 
ASPECTS: Processes and good practices related to leadership and management 
 
From the description of the work provided by Prof. Seppo Meri, the RC shows excellent synergy and more 
synergy could be obtained from the groups in Viikki Campus. The research environment, with closeness to 
hospital, Biomedicum and FIMM, provides several opportunities for operational handling of very expensive 
infrastructure present in Meilahti campus. Doctoral programmes in the Meilahti area is also an excellent 
choice to collaborate in the doctoral training. 
Recommendation: The University and hospital should consider creating additional positions and 
improve the research environment. 
2.6 Leadership and management in the researcher community 
 Description of  
 the execution and processes of leadership in the RC 
 how the management-related responsibilities and roles are distributed in the RC 
 how the leadership- and management-related processes support 
 high quality research 
 collaboration between principal investigators and other researchers in the RC 
 the RC’s research focus 
 strengthening of the RC’s know-how 
 Identification of the RC’s strengths and challenges related to leadership and management, and the 
actions planned for developing the processes 
ASPECTS: Processes and good practices related to leadership and management 
 
The panel is totally convinced that the RC is well led under its current structure and well managed, and all 
the group leaders strongly support high quality research and collaboration, and RC has an excellent 
environment also for young group leaders. The fusion of RC Lokki to this RC is an obvious choice, and the 
RC should try to attract Professor Dennis Bamford from Viikki and his groups to consider a possibility for a 
strong consortium in this important research area. 
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2.7 External competitive funding of the RC 
• The RCs were asked to provide information of such external competitive funding, where: 
• the funding decisions have been made during 1.1.2005–31.12.2010, and  
• the administrator of the funding is/has been the University of Helsinki 
• On the e-form the RCs were asked to provide: 
1) The relevant funding source(s) from a given list (Academy of Finland/Research Council, 
TEKES/The Finnish Funding Agency for Technology and Innovation, EU, ERC, foundations, other 
national funding organisations, other international funding organizations), and 
2) The total sum of funding which the organisation in question had decided to allocate to the RCs 
members during 1.1.2005–31.12.2010. 
Competitive funding reported in the text is also to be considered when evaluating this point. 
ASPECTS: Scientific quality, scientific significance, societal impact, innovativeness and future significance 
 
The competitive funding from all the sources is excellent and shows the scientific strongness of this RC. 
The RC has also obtained significant funding from EU and ERC. Other national funding like 7.8 m€ from 
AF shows the competitive position of this RC, and EVO funding has also been at a very high level. 
The RC competes well with comparative groups in other European countries and participates actively 
in EU-networks. 
2.8 The RC’s strategic action plan for 2011–2013 
• RC’s description of their future perspectives in relation to research and doctoral training. 
ASPECTS: Scientific quality, scientific significance, societal Impact, processes and good practices related to 
leadership and management, national and international collaboration, innovativeness, future significance 
 
Members of this RC have attracted external funding for the future, and therefore the actions in 2011–2013 
are to be well funded. The RC has described detailed specific aims for scientific research and doctoral 
training, and they mention that collaboration between Meilahti and Viikki should be increased and they are 
trying to establish a new doctoral programme in Infection Biology. 
Recommendation: as previously mentioned, fuse RC Lokki first and then discuss with RC Dennis 
Bamford about more formal co-operation if possible in order to create an outstanding research 
programme covering basic and clinical aspects of microbiology including high standard research tradition 
in Finnish virology and infection. 
2.9 Evaluation of the category of the RC in the context of entity of 
the evaluation material (1-8) 
The RC’s fitness to the chosen participation category. 
Category 1. The research of the participating community represents the international cutting edge in its field. 
 
The RC perfectly fits within the chosen participation category. 
Numeric evaluation: 4 (Excellent) 
2.10 Short description of how the RC members contributed the 
compilation of the stage 2 material 
The compilation of the evaluation material was clearly done by all the group leaders in this RC, and the 
final material was described by Professor Meri. 
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2.11 How the UH’s focus areas are presented in the RC’s research 
Focus area 2: The basic structure of life 
 
The RC is clearly in UH’s focus area. 
2.12 RC-specific main recommendations 
Recommendations: 
1. Fuse RC Lokki into your RC. 
2. Include all the young group leaders into your RC. 
3. Discuss with RC Bamford how to make a common Meilahti/Viikki consortium if possible. 
4. Try to recruit more young independent group leaders. 
2.13 RC-specific conclusions 
InfBio is an excellent RC within UH with excellent international reputation and many participating groups 
having complementary knowledge in the infection biology. Complement research and virology research 
are the strongest areas in this RC, and RC works in many aspects of microbiology and immunology, and 
their focus area is in microbial virulence. 
The panel has a very positive impression on the work done in this RC concerning both in the past and 
the future perspective. A stronger support for their RC by the university and hospital should be 
considered. The fusion with RC Lokki and even RC Bamford could result into outstanding RC. 
2.14 Preliminary findings in the University-level evaluation 
The research, doctoral training and the focus of this RC are clearly excellent. National and international 
collaboration is well described and effective. The amount of external funding is impressive, and the 
production of PhDs is very high. Leadership and management and strategic action plans are very well 
described and clear. The RCs would be much stronger after fusing RC Lokki into the current one. To make 
the RC outstanding then this RC should discuss with RC Bamford about a possibility to make a consortium 
between them. The societal impact is clear-cut; new infectious diseases are emerging all the time and 
better collaboration between e.g. basic virology and clinical virology is obvious to break the borders 
between Meilahti and Viikki campuses. 
The RC has also a huge potential in translational medicine. 
  
20 
 
 
 
 
21 
 
3 Appendices 
A. Original evaluation material 
a. Registration material – Stage 1 
b. Answers to evaluation questions – Stage 2 
c. List of publications 
d. List of other scientific activities 
B. Bibliometric analyses 
a. Analysis provided by CWTS/University of Leiden 
b. Analysis provided by Helsinki University Library (66 RCs) 
 
 
 
 
 
International evaluation of research and doctoral training 
at the University of Helsinki 2005-2010 
 
         RC-SPECIFIC MATERIAL FOR THE PEER REVIEW 
 
 
 
 
NAME OF THE RESEARCHER COMMUNITY:  
Infection Biology (InfBio) 
 
LEADER OF THE RESEARCHER COMMUNITY:  
Professor Seppo Meri, Haartman Institute, Faculty of medicine 
 
RC-SPECIFIC MATERIAL FOR THE PEER REVIEW: 
 Material submitted by the RC at stages 1 and 2 of the evaluation 
- STAGE 1 material: RC’s registration form (incl. list of RC participants in an excel table) 
- STAGE 2 material: RC’s answers to evaluation questions 
 TUHAT compilations of the RC members’ publications 1.1.2005-31.12.2010 
 TUHAT compilations of the RC members’ other scientific activities 1.1.2005-31.12.2010 
 Web of Science(WoS)-based bibliometrics of the RC’s publications data 1.1.2005-31.12.2010 
(analysis carried out by CWTS, Leiden University) 
NB! Since Web of Science(WoS)-based bibliometrics does not provide representative results for most RCs representing 
humanities, social sciences and computer sciences, the publications of these RCs will be analyzed by the UH Library 
(results available by the end of June, 2011) 
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INTERNATIONAL EVALUATION OF RESEARCH AND DOCTORAL TRAINING AT THE 
UNIVERSITY OF HELSINKI  
 
RC-SPECIFIC STAGE 1 MATERIAL (registration form) 
 
 
 
 
Name: MERI, Seppo 
E-mail:  
Phone: +358-50-5812462 
Affiliation: Haartman Institute 
Street address: Haartmaninkatu 3, 00290, Helsinki 
 
 
Name of the participating RC (max. 30 characters): Infection Biology 
Acronym for the participating RC (max. 10 characters): InfBio 
Description of the operational basis in 2005-2010 (eg. research collaboration, joint doctoral training 
activities) on which the RC was formed (MAX. 2200 characters with spaces): Our research community is 
based on a research program called Infection Biology (InfBio) that is principally operating at the Medical 
Faculty of the University of Helsinki. The RC is composed of 10 individual research teams that focus on 
microbe-host interactions. At the UH we represent the major consortium working on microbes with 
medical relevance, thereby covering infection, host response, diagnostics and vaccine development. InfBio 
was founded as a voluntary consortium about 10 years ago and as a research program it has existed for 7 
years. We collaborate intensely, organise joint seminars (weekly Haartman Seminars, annual Microbial 
Pathogenesis Days and annual InfBio Days) that are essential parts of doctoral training. PhD candidates get 
training in the laboratories of different PIs of the consortium. As such the community is coherent and has a 
common focus – microbial virulence. 
 
 
Main scientific field of the RC’s research: medicine, biomedicine and healt sciences 
RC's scientific subfield 1: Microbiology 
RC's scientific subfield 2: Infectious Diseases 
RC's scientific subfield 3: Virology 
RC's scientific subfield 4: Immunology 
Other, if not in the list: Bacteriology, Parasitology 
 
 
Participation category: 1. Research of the participating community represents the international cutting 
edge in its field 
1 RESPONSIBLE PERSON 
2 DESCRIPTION OF THE PARTICIPATING RESEARCHER COMMUNITY (RC) 
3 SCIENTIFIC FIELDS OF THE RC 
4 RC'S PARTICIPATION CATEGORY 
 
 
2 
 
INTERNATIONAL EVALUATION OF RESEARCH AND DOCTORAL TRAINING AT THE 
UNIVERSITY OF HELSINKI  
 
RC-SPECIFIC STAGE 1 MATERIAL (registration form) 
 
 
Justification for the selected participation category (MAX. 2200 characters with spaces):  Our research 
community represents international cutting edge because, as individual research groups, we are doing 
pioneering and breakthrough research in our field. Most of our PIs are international leaders in their 
respective subfields. As a community we are exemplary as an efficient and high quality doctoral training 
environment. Our consortium has also attracted a high number of foreign PhD and postdoctoral students, 
probably more than to any other comparable unit at the University of Helsinki. 
 
 
Public description of the RC's research and doctoral training (MAX. 2200 characters with spaces): 
Infection Biology (InfBio) research community is composed of 10 named individual research teams and 
collaborating groups that focus on microbe-host interactions. Infections pose a great challenge to mankind. 
They change their nature and keep on surprising us in new forms. Antibiotic resistance among microbes is 
increasing constantly, new microbes emerge and new ways to combat infections will be needed. At the 
University of Helsinki we represent the major consortium working on microbes with medical relevance, 
thereby covering infection, host response, diagnostics and vaccine development. The key word in our work 
is microbial virulence. What are the mechanisms and molecules that make a microbe virulent – a 
pathogen? 
 
The teams of InfBio are led by top class scientists, who cover “the microbial world” ranging from tiny 
viruses to bacteria (chlamydiae, salmonella, yersinia and other enteric bacteria, streptococci, borrelia), 
single cell parasites (malaria) and several-meter-long parasitic worms. The community is very active in 
doctoral training and has attracted a large number of foreign students to do their PhD or postdoctoral 
work. The groups constitute a continuum of various functional aspects in microbial virulence research 
(host-microbe interactions, adhesion, innate response, signaling, adaptive response, immune evasion and 
virulence factors).  The investigators have found new microbes, developed new diagnostics, solved 
pathogenetic mechanisms in diseases, participated in vaccine development, analysed the roles of microbes 
in inflammatory diseases, in allergy as well as in securing biosafety. 
Significance of the RC's research and doctoral training for the University of Helsinki (MAX. 2200 
characters with spaces): Infections pose one of the biggest threats to mankind. Our research community is 
based on a research program called Infection Biology (InfBio). It is composed of 10 individual research 
teams that focus on microbe-host interactions  At the UH we represent the major consortium working on 
microbes with medical relevance, thereby covering infection, host response, diagnostics and vaccine 
development. The teams of InfBio are led by top class scientists, who cover “the microbial world” 
(especially viruses, chlamydiae, enteric bacteria, streptococci, borreliae, candida, malaria and parasitic 
worms). In another dimension, the groups constitute a continuum of various functional aspects in microbial 
virulence research (host-microbe interactions, adhesion, innate response, signaling, adaptive response, 
immune evasion and virulence factors).  All these are very important in the development of diagnostics, 
solving pathogenetic mechanisms in diseases, vaccine development, deciphering the roles of microbes in 
inflammatory diseases and in allergy as well as in securing biosafety.  
 
5 DESCRIPTION OF THE RC'S RESEARCH AND DOCTORAL TRAINING 
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INTERNATIONAL EVALUATION OF RESEARCH AND DOCTORAL TRAINING AT THE 
UNIVERSITY OF HELSINKI  
 
RC-SPECIFIC STAGE 1 MATERIAL (registration form) 
 
 
Entirely new research opportunities are provided by the post-genomic era, with thousands of novel 
bacterial, fungal and viral genomes sequenced. This will be of great importance to the University of Helsinki 
and research community at large. We have identified many virulence factors, their interaction partners and 
novel interactions. We have even discovered new organisms (viruses and a worm), for which the University 
of Helsinki can be proud of. 
 
The community is particularly active in doctoral training. During the last 5 years we have trained nearly 50 
PhD’s into completion. This provides a basis for part of the funding of the University of Helsinki. In addition 
to the high quality scientific research, PhD training as well as cohesion and synergy between the groups 
have been boosted by regular meetings (e.g. by “Microbial Pathogenesis” meetings and “InfBio days”).  
 
Our impact radiates also to clinical aspects and general welfare. Front line research on diagnostics has 
made it more accurate and efficient. This reflects an impact on the society in the form of better health care. 
Keywords: infection, microbe, zoonosis, hantavirus, DNA viruses, bacteria, yersinia, salmonella, omptin, 
vaccine, allergy, complement, SH3, hemolytic uremic syndrome, factor H, immunity, diagnostics 
 
 
Justified estimate of the quality of the RC's research and doctoral training at national and international 
level during 2005-2010 (MAX. 2200 characters with spaces): The quality of research in infection biology is 
inherently linked to the research area itself. The studies involve high level conceptual analyses on 
fundamental and intellectually challenging questions (self-nonself discrimination, loss of tolerance, 
development of allergy, evolution, species specificity of infections, virulence mechanisms, nature of 
microbial life, microbial mimicry). On the other hand, the research is closely related to practical applications 
like diagnostics, better therapy, drugs and vaccines for preventing serious diseases like encephalitis and 
meningitis.  
 
In many areas our researchers belong to the world leading groups. They are well cited with the total 
number of citations among the 10 PIs being well over 64 000 (average over 6400/PI). Hirsch-indices of our 
PIs range from 21 to 86 (average 39.2). 
 
In doctoral training we produce nearly 10 PhDs per year on the average. These represent high quality 
because all dissertations are based on research articles (3-5 per thesis) published in internationally 
renowned journals. The quality of our students is also exemplified by the high number of students in 
graduate schools, to which the entry is based on competitive selection. We have had approximately 20 
students in graduate schools.  We have also been involved in the administration and development of the 
graduate schools and Prof. Risto Renkonen is currently heading one of them. 
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Our research has proved to be attractive to foreign students. During the past 5 years we have trained a 
number of foreign students, both PhDs and postdoctoral fellows. The research topics are international and 
global already in nature. Infections do not know borders, but are easily transferred from one country to 
another. We have Marie Curie students and students supported by various other international exchange 
programs. 
 
The PIs of the consortium are involved in various national and international activities related to PhD 
training. For example, prof. Seppo Meri is a founding member and the current Secretary General of 
ORPHEUS, an association devoted to the development of PhD training and graduate schools in biomedicine 
in Europe. 
Comments on how the RC's scientific productivity and doctoral training should be evaluated (MAX. 2200 
characters with spaces): The scientific productivity of the RC can be assessed by the usual bibliometric 
means using objective analyses performed by the ISI. Web of Science provides unbiased and reliable 
reports of scientific activity in the form of the number of publications, the number of citations and 
individual Hirsch-indices. We can provide the numbers of citations for each PI, Hirsch- indices and 
bibliometric profiles, where the total numbers of publications and citations per year are indicated.  
 
Although numeric bibliometric data are relatively reliable and can be nowadays easily generated we 
consider comparison by peers as the most important way to analyse research output and its significance in 
the field. Appreciation among colleagues is also reflected in the presence of a researcher in scientific 
committees, positions of trust locally (Dean, Head of Institute, Heads of Departments) or internationally 
(Scientific Organizations, Evaluation Committees for grants, Committees to evaluate Research Institutes, 
Centers of Excellence, Editors in journals, Editorial Board Memberships). 
 
Our general publishing policy is to keep a “healthy profile”. Although we have published in top journals like 
Cell, EMBO J and PNAS, most of our published work has appeared in the top journals of our fields. Thereby 
we aim at reaching the right readership and having the greatest impact.  
 
Additional criteria for evaluation include the careers of PhDs after they have finished their degrees. Many 
of our PhDs have moved abroad to well known research groups and institutes. Another criterion should be 
networking and collaboration between individual groups. Each team already has a wide number of 
collaborations in their fields. These include partnering in the ERANET Pathogenomics network, in European 
Network of Excellence “Europathogenomics”, in the Marie- Curie International Training Network and in EU-
funded consortia (e.g. HIV drug discovery consortium participation by Saksela).  
 
Some of our PhDs received their degrees with honors. Prizes have been given to our PIs. E.g. the Eric K. 
Fernström Nordic prize in 2010 was given to professor Antti Vaheri and the Medix 2010 prize to professor 
Risto Renkonen. 
LIST OF RC MEMBERS
NAME OF THE RESEARCHER COMMUNITY: InfBio
RC-LEADER S. Meri
CATEGORY 1
Last name First name
PI-status 
(TUHAT, 
29.11.2010)
Title of research and 
teaching personnel Affiliation 
1 Vaheri Antti x Professor Faculty of medicine, Haartman Institute
2 Hepojoki Jussi Doctoral candidate Faculty of medicine, Haartman Institute
3 Huhtamo Eili Postdoctoral researcher Faculty of medicine, Haartman Institute
4 Jääskeläinen Anne Postdoctoral researcher Faculty of medicine, Haartman Institute
5 Jääskeläinen Anu Doctoral candidate Faculty of medicine, Haartman Institute
6 Kuivanen Suvi Doctoral candidate Faculty of medicine, Haartman Institute
7 Kurkela Satu Postdoctoral researcher Faculty of medicine, Haartman Institute
8 Lindh Erika Doctoral candidate Faculty of medicine, Haartman Institute
9 Putkuri Niina Doctoral candidate Faculty of medicine, Haartman Institute
10 Salmenperä Perttu Doctoral candidate Faculty of medicine, Haartman Institute
11 Sane Jussi Doctoral candidate Faculty of medicine, Haartman Institute
12 Sironen Tarja Postdoctoral researcher Faculty of medicine, Haartman Institute
13 Strandin Tomas Doctoral candidate Faculty of medicine, Haartman Institute
14 Tonteri Elina Doctoral candidate Faculty of medicine, Haartman Institute
15 Wang Hao Doctoral candidate Faculty of medicine, Haartman Institute
16 Enzerink Anna Doctoral candidate Faculty of medicine, Haartman Institute
17 Koskinen Walter Doctoral candidate Faculty of medicine, Haartman Institute
18 Li Xiao-Dong Doctoral candidate Faculty of medicine, Haartman Institute
19 Räsänen Kati Doctoral candidate Faculty of medicine, Haartman Institute
20 Virtanen Oskari Doctoral candidate Faculty of medicine, Haartman Institute
21 Plyusnin Alexander x University lecturer Faculty of medicine, Haartman Institute
22 Plyusnina Angelina Senior Researcher Faculty of medicine, Haartman Institute
23 Alminaite Agne Doctoral candidate Faculty of medicine, Haartman Institute
24 Katz Anna Doctoral candidate Faculty of medicine, Haartman Institute
25 Razzauti Maria Doctoral candidate Faculty of medicine, Haartman Institute
26 Jääskeläinen Kirsi Doctoral candidate Faculty of medicine, Haartman Institute
27 Rönnberg Tuomas Doctoral candidate Faculty of medicine, Haartman Institute
28 Singh Vijay Doctoral candidate Faculty of medicine, Haartman Institute
29 Skurnik Mikael x Professor Faculty of medicine, Haartman Institute
30 Mattinen Laura postdoctoral Researcher Faculty of medicine, Haartman Institute
31 Salmenlinna Saara postdoctoral Researcher Faculty of medicine, Haartman Institute
32 Hyytiäinen Heidi postdoctoral Researcher Faculty of medicine, Haartman Institute
33 Li Chun-Mei postdoctoral Researcher Faculty of medicine, Haartman Institute
34 Sengupta Datta Neeta postdoctoral Researcher Faculty of medicine, Haartman Institute
35 Kiljunen Saija researcher Faculty of medicine, Haartman Institute
36 Pinta Elise researcher Faculty of medicine, Haartman Institute
37 Li Zhilin doctoral candidate Faculty of medicine, Haartman Institute
38 Blom Tea researcher Faculty of medicine, Haartman Institute
39 Biedzka-Sarek Marta doctoral candidate Faculty of medicine, Haartman Institute
40 Salem Mabruka researcher Faculty of medicine, Haartman Institute
41 Knapska Katarzyna researcher Faculty of medicine, Haartman Institute
42 Meri Seppo x Professor Faculty of medicine, Haartman Institute
43 Jarva Hanna x University Lecturer Faculty of medicine, Haartman Institute
44 Freitag Tobias Postdoctoral researcher Faculty of medicine, Haartman Institute
45 Friberg Nathalie Doctoral candidate Faculty of medicine, Haartman Institute
46 Ho Derek Postdoctoral researcher Faculty of medicine, Haartman Institute
47 Holmberg Ville Postdoctoral researcher Faculty of medicine, Haartman Institute
48 Kalanti Annika Doctoral candidate Faculty of medicine, Haartman Institute
49 Khattab Ayman Postdoctoral researcher Faculty of medicine, Haartman Institute
50 Lavikainen Antti Doctoral candidate Faculty of medicine, Haartman Institute
51 Lokki Inkeri Doctoral candidate Faculty of medicine, Haartman Institute
52 Riva Rauna Doctoral candidate Faculty of medicine, Haartman Institute
53 Tissari Jorma Doctoral candidate Faculty of medicine, Haartman Institute
54 Jokiranta T. Sakari x University Lecturer Faculty of medicine, Haartman Institute
55 Meri Taru Postdoctoral Researcher Faculty of medicine, Haartman Institute
56 Lehtinen Markus J. Doctoral candidate Faculty of medicine, Haartman Institute
57 Haapasalo Karita Doctoral candidate Faculty of medicine, Haartman Institute
58 Koskinen Aino Doctoral candidate Faculty of medicine, Haartman Institute
59 Bhattacharjee Arnab Doctoral candidate Faculty of medicine, Haartman Institute
60 Amdahl Hanne Doctoral candidate Faculty of medicine, Haartman Institute
61 Hyvärinen Satu Doctoral candidate Faculty of medicine, Haartman Institute
62 Puolakkainen Mirja x Clinical Instructor Faculty of medicine, Haartman Institute
63 Markkula Evelina post-doctoral researcher Faculty of medicine, Haartman Institute
64 Mannonen Laura doctoral candidate Faculty of medicine, Haartman Institute
65 Niemi Suvi researcher Faculty of medicine, Haartman Institute
66 Korhonen Juha researcher Faculty of medicine, Haartman Institute
67 Hulkkonen Jaakko researcher Faculty of medicine, Haartman Institute
68 Häivälä Reetta med student Faculty of medicine, Haartman Institute
69 Renkonen Risto x Professor, Dean of the Faculty of Medicine
Faculty of Medicine, Haartman Institute, 
Transplantation Laboratory
70 Mattila Pirkko Senior Researcher
Faculty of Medicine, Haartman Institute, 
Transplantation Laboratory
71 Toppila-Salmi Sanna Senior Researcher
Faculty of Medicine, Haartman Institute, 
Transplantation Laboratory
72 Renkonen Jutta University  Researcher
Faculty of Medicine, Haartman Institute, 
Transplantation Laboratory
73 Saksela Kalle x Professor Faculty of medicine, Haartman Institute
74 Peterlin Matija Professor (FiDiPro) Faculty of medicine, Haartman Institute
75 Järviluoma Annika Postdoctoral Researcher Faculty of medicine, Haartman Institute
76 Kazlauskas Arunas Postdoctoral Researcher Faculty of medicine, Haartman Institute
77 Kesti Tapio Postdoctoral Researcher Faculty of medicine, Haartman Institute
78 Kleino Iivari Postdoctoral Researcher Faculty of medicine, Haartman Institute
79 Lavilla-Alonso Sergio Doctoral candidate Faculty of medicine, Haartman Institute
80 Schmotz Constanze Doctoral candidate Faculty of medicine, Haartman Institute
81 Ylösmäki Erkko Doctoral candidate Faculty of medicine, Haartman Institute
82 Ylösmäki Leena Doctoral candidate Faculty of medicine, Haartman Institute
83 Zumer Kristina Doctoral candidate Faculty of medicine, Haartman Institute
84 Hedman Klaus x Professor Faculty of medicine, Haartman Institute
85 Söderlund-Venermo Maria x University researcher Faculty of medicine, Haartman Institute
86 Franssila Rauli Postdoctoral researcher Faculty of medicine, Haartman Institute
87 Chen Tingting Doctoral candidate Faculty of medicine, Haartman Institute
88 Kantola Kalle Doctoral candidate Faculty of medicine, Haartman Institute
89 Kumar Arun Doctoral candidate Faculty of medicine, Haartman Institute
90 Sadeghi Reza Doctoral candidate Faculty of medicine, Haartman Institute
91 Norja Päivi Doctoral candidate Faculty of medicine, Haartman Institute
92 Väisänen Elina Doctoral candidate Faculty of medicine, Haartman Institute
93 Filippone Claudia Postdoctoral Researcher Faculty of medicine, Haartman Institute
94 Aalto Sanna Doctoral candidate Faculty of medicine, Haartman Institute
95 Hokynar Kati Doctoral candidate Faculty of medicine, Haartman Institute
96 Kakkola Laura Doctoral candidate Faculty of medicine, Haartman Institute
97 Westerlund-Wikström Benita x University lecturer
Department of Biosciences, Faculty of Biological 
and Environmental Sciences
98 Majander Katariina Doctoral candidate
Department of Biosciences, Faculty of Biological 
and Environmental Sciences
99 Anton Lena Doctoral candidate
Department of Biosciences, Faculty of Biological 
and Environmental Sciences
100 Kylväjä Riikka Doctoral candidate
Department of Biosciences, Faculty of Biological 
and Environmental Sciences
101 Lehti Timo Doctoral candidate
Department of Biosciences, Faculty of Biological 
and Environmental Sciences
102 Korhonen Timo K x Professor General Microbiology, UH
103 Virkola Ritva University lecturer General microbiology, UH
104 Lähteenmäki Kaarina University lecturer General Microbiology, UH
105 Juuti Katri Senior reseacher General Microbiology, UH
106 Edelman Sanna Doctoral candidate Genral Microbiology, UH
107 Lobo Leandro Dotoral candidate General Microbiology, UH
108 Antikainen Jenni Dioctoral candidate General Microbiology, UH
109 Ramu Paivi Doctoral candidate General Microbiology, UH
110 Haiko Johanna Doctoral candidate General Microbiology, UH
111 Kainulainen Veera Doctoral candidate General Microbiology, UH
112 Suomalainen Marjo Doctoral candidate General Microbiology, UH
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Name of the RC’s responsible person: MERI, Seppo 
E-mail of the RC’s responsible person:   
Name and acronym of the participating RC: Infection Biology, InfBio 
The RC’s research represents the following key focus area of UH: 2. Elämän perusrakenne – The basic 
structure of life 
Comments for selecting/not selecting the key focus area: The UH key focus areas do not quite reflect the 
biological or biomedical sciences.  
Our area - "Infection Biology" - however, ranges from the very origin of life and its various forms to "Clinical 
sciences". It has also a lot to do with "Welfare and safety". This is because  infectious diseases are a great 
risk to our welfare and safety and, at the end, infections pose one of the biggest threats to mankind. 
Because of increasing microbial resistance to antibiotics the "Farewell to antibiotics" -day is getting closer 
and we need to get prepared to using other means to combat infections. 
 
 
 Description of the RC’s research focus, the quality of the RC’s research (incl. key research 
questions and results) and the scientific significance of the RC’s research for the research 
field(s).  
Infection biology (InfBio) research consortium focuses on microbe-host interactions. The focus is in-line 
with that of the Faculty of Medicine, which together with Helsinki University Central Hospital (HUS) has 
defined “infections and inflammations” as one of its primary research focuses.  
The teams of InfBio RC are led by top class scientists, whose roles cover different areas and target 
organisms in microbial virulence research.  
 
Bacterial virulence factors. Chimeric autotransporter adhesins are essential virulence factors in many 
human pathogens including Yersinia spp.  and meningococcus. Monomeric and chimeric 
autotransporters are the smallest working molecular machines, transporting the “passenger domain” 
through a beta-barrel membrane pore, without assistance of an obvious energy source. The group led 
by Skurnik, (with Goldman, Viikki) showed that the YadA-head is a novel left-handed beta-roll 
(Nummelin, EMBO J, 2004). Collaboration between Skurnik and Meri elucidated the role of YadA in 
complement resistance, showing that it binds complement regulators, factor H and C4bp and thereby 
prevents complement-mediated killing (Biedzka-Sarek, Infect Immun, 2008; Kirjavainen PLOS Pathog, 
2008). 
The group of Westerlund-Wikström has studied at the molecular level the secretion, biogenesis and 
function of bacterial surface proteins, and protein appendages involved in infectious processes. In 
addition, they apply bacterial secretion systems and protein appendages biotechnologically as 
extracellular secretion and surface display machineries for heterologous proteins. They use wide range 
of modern technologies, which aim at understanding basic mechanisms behind infectious diseases in 
humans, and generate applications e.g. in preventive medicine. Their novel secretion technology 
published in Nature Biotechnology was cited in Faculty of 1000 in 2005. In the group of Korhonen, the 
emphasis has been on the molecular biology and pathogenomics of invasive pathogens and on bacteria-
host interactions. Specific topics have included the function and evolution of surface proteases, how 
they undermine innate immune defenses, i.e. enhancement of plasminogen activation, damage of 
BACKGROUND INFORMATION 
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fibrinolysis control, as well as degradation of complement proteins and antimicrobial peptides. This 
work has led to many high quality publications and top class training of many field microbiologists. 
Host-nonhost discrimination. Studies by Jokiranta (with Goldman) led first to determining the structure 
of the surface-recognition domain of complement factor H (SCR 19-20, Jokiranta, EMBO J ,2006) and 
recently the structure of the SCR 19-20: C3d complex  (Kajander, PNAS, 2011). This has provided an 
explanation of how complement, a crucial part of innate immune system, determines between host and 
nonhost surfaces. Consequently, a 50-year old mystery of how just a few molecules, C3 and factor H, 
discriminate host surfaces from the huge number of foreign microbial surfaces, has been solved. The 
results provided an explanation on why mutations in either factor H or C3 give rise to atypical hemolytic 
uremic syndrome, a devastating disease often leading to the death of a patient, because of 
complement-mediated destruction of patient’s vascular endothelium and blood cells. 
Immune evasion. Many microbes are resistant to complement-mediated killing. These are often human 
or animal pathogens. The Meri group has observed that virulence often depends on resistance to 
complement. They have identified a new family of complement inhibitors from the Lyme-disease B. 
burgdorferi spirochetes and e.g. pneumococci (protein Hic, which binds factor H). They also identified 
PorA in Meningococci as a C4pb binding protein (Jarva, J Immunol, 2005). Group B meningococcus 
(Neisseria meningitidis) is the most important causative agent of meningitis in the Western world. No 
vaccines are available. Meri has proposed the use of the receptor of the complement regulator binding 
protein as vaccine (Meri, Vaccine, 2008).  This concept has now been realised because of the promising 
vaccine candidate against group B meningococcus discovered by whole-genome screening by Novartis 
(Giuliani, PNAS, 2006) turned out to be a factor H binding protein (FHBP). The Novartis FHBP-vased 
vaccine is now in Phase III clinical trials in Finland and many other countries. 
Viral immune evasion. The pathogenicity factor Nef is a key protein in immune evasion by HIV, and Nef-
deleted SIV-strains show potential as attenuated live vaccines. Key aspects of the molecular functions of 
Nef have been characterised by the Saksela group. The Src-homology 3 (SH3) domain is the most 
commonly found modular protein domain. Many microbial pathogens, e.g. HIV, exploit cellular SH3-
mediated processes. Studies by Saksela on SH3-binding by the HIV-1 Nef protein provided the first 
example of the high-jacking of cellular protein interaction networks by a pathogen via SH3-binding, and 
have led to the elucidation of the molecular determinants that contribute to the specificity and affinity 
in SH3-mediated protein interaction (Saksela, EMBO J 1995; Lee, Cell,1996).  The Saksela laboratory 
cloned and assembled a phage-display library of all 296 SH3-domains in the human genome (Kärkkäinen, 
EMBO Rep, 2006). This is a powerful tool for unbiased and rapid identification of SH3-mediated protein 
interactions. It will lead to a comprehensive understanding of all SH3-mediated protein interactions. 
Development of diagnostics and discovery of new viruses. The Hedman group has invented IgG-avidity 
methods that have globally overwhelmed the serodiagnostics of infectious diseases. The Hedman group 
has together with the Söderlund-Venermo group discovered the variant (genotype 2) of human 
parvovirus B19, and the life-long persistence of this pathogen in the human body, denoted as the 
bioportfolio. Their research in general addresses innovative diagnostics and molecular biology of 
infections, in the angle of clinical impact and pathogenicity. It now focuses on emerging microbes: nine 
new species and an entire family of small-sized DNA viruses of humans. 
Zoonotic infections. The groups of Plyusnin and Vaheri have for long studied viral zoonoses, more 
specifically the molecular biology, genetics and evolution of hantaviruses, and molecular epidemiology 
of the associated diseases. They have discovered new hantaviruses. Plyusnin is applying a variety of 
approaches, from molecular studies to inferring phylogenies and interactomics. The group is pioneering 
in several fields, e.g. in recovery and analysis of complete hantavirus genomes and quasispecies analysis. 
Vaheri is already a legend in Finnish research. He is one the most cited scientists in Finland and a role 
model for many young investigators. He is a highly appreciated member of the  InfBio RC.  According to 
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a recent evaluation, he is “… an outstanding scientist known worldwide for his numerous high-impact 
work”.  
Systems biology. The group of Renkonen has applied a systems biology approach, including large-scale 
data collections, transcriptomics, proteomics, interactomics and pathway analyses. They aim at 
understanding the basic mechanisms of immunological diseases in human patients. Their novel 
observations in acute allergy and new active role of epithelium in the pathogenesis of this disease have 
generated several publications and both national and international recognition. The Renkonen group 
was awarded The Medix Prize 2010 for the best medical paper in Finland, and European Academy of 
Allergy and Clinical Immunology (EAACI) selected this work as one of the few “Hot Topic Lectures” at the 
annual meeting with 5000 participants (2009). 
 Ways to strengthen the focus and improve the quality of the RC’s research. 
1. Focus on the most relevant and important issues with scientific, practical and medical significance.  
2. Consistently aim at a higher research level by following and concentrating on the most promising 
leads provided by own results. This goal will be facilitated by hard work and transfer of ideas between 
the junior and senior investigators. 
3. Attempting to overcome the “publication barrier” that seems to prevent us from publishing in the 
most prominent scientific journals. This can be done by ensuring the quality and the innovativeness of 
the work, by not imposing the barriers ourselves and by participating more efficiently in the 
international community. 
4. Increase collaboration to be able to always use the best, and not the second best, available methods 
and approaches. This is also essential for creativity. Contacts of molecular biology researchers from 
Viikki with the more medically oriented researches in Meilahti should be increased. 
5. Exploit more extensively the most recent methodology. 
6. Organise meetings solely devoted on solving key scientific problems. 
 
 
  How is doctoral training organised in the RC? Description of the RC’s principles for recruitment and 
selection of doctoral candidates, supervision of doctoral candidates, collaboration with faculties, 
departments/institutes, and potential graduate schools/doctoral programmes, good practises and 
quality assurance in doctoral training, and assuring good career perspectives for the doctoral 
candidates/fresh doctorates.  
The InfBio RC is particularly active in doctoral training. During the last 5 years we have trained 39 PhD’s 
(including 9 MD/PhDs) into completion and currently there are 53 doctoral candidates (including 7 
MD/PhD candidates) within the RC.  
 
Recruitment and selection   
To select doctoral candidates a strong interest in infection biology related research topics and an 
aptitude or potential for biomedical research are major criteria. PIs in the RC have a close contact with a 
large amount of students in two campuses enabling active recruitment of the best undergraduate 
students.  
Each research group in the InfBio RC announces their open doctoral candidate positions and selects 
their own students independently but the announcements are also distributed within RC to facilitate 
horizontal recruitment.  
2 PRACTISES AND QUALITY OF DOCTORAL TRAINING (MAX. 8800 CHARACTERS WITH SPACES) 
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It is also possible to undertake the PhD studies by medical doctors at the same time when they do 
clinical practice. This is encouraged by the InfBio RC to boost the clinical contact of the research groups.  
 
Supervision  
The doctoral training is based on different modes of education as follows.  
(a) Supervision by PI and possibly postdoctoral researchers in the group including planning, material 
collection, data analyses and writing articles. 
(b) Regular group meetings are organized weekly or bimonthly and the meetings serve as a platform for 
progress reports and research talks presented by the students.  
(c) Scientific meetings of the RC are organized twice a year (annual “Microbial Pathogenesis” day and 
“InfBio days”) and the InfBio RC is the main organizer of weekly Haartman seminars. Participation of 
the PhD students in these meetings/seminar is documented and each student needs to give two 
presentations in these occasions during the PhD studies boosting also cohesion and synergy between 
the groups. In addition, the students in graduate schools present their work in the graduate school 
meetings. 
(d) Each doctoral candidate needs to participate in international scientific conferences and national or 
international training courses according to the individual PhD study plan. 
  
Collaboration  
A total of 20 of the current doctoral students (38%) have been accepted or affiliated to graduate 
schools. We have also been involved in the administration and development of the graduate schools 
(Prof. R. Renkonen is heading one of them) and graduate school method courses.  
The PIs of the InfBio RC are involved in various national and international activities related to PhD 
training. For example, prof. S. Meri is a founding member and the Secretary General of ORPHEUS 
developing PhD training and graduate schools in biomedicine in Europe.  
The international contacts in PhD training are important, in particular the international graduate school, 
the Network of Excellence, and EuroPathoGenomics, where several of the PIs are involved and which 
covers all major institutes on bacterial pathogenomics in Europe. These networks provide platforms for 
teaching plus a chances for students to create own contacts abroad. 
 
Good practices 
Students are instructed and required to conduct research in a responsible manner and according to 
ethical guidelines of the University of Helsinki 
(http://www.helsinki.fi/tutkimus/tutkimuseettisensuositus.doc), as well as the good scientific practice 
(http://www.tenk.fi/JulkaisutjaOhjeet/htkfi.pdf). These guidelines are followed when research projects 
are prepared and implemented. Doctoral students are encouraged to obtain teaching experience, 
usually by serving as teachers in the practical laboratory courses.  
It is documented that each student going for biomedical laboratory work has read instructions 
concerning laboratory safety, waste handling, and when applicable also microbial hazards, radioactive 
work, and animal handling. These instructions (except for animal handling) have been generated by the 
InfBio RC personnel. 
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Quality assurance 
To improve quality of PhD training thesis committees are used. In the InfBio RC the doctoral candidates 
are encouraged to have a thesis committee latest in the beginning of the third year of studies. Currently 
70% of students at this stage have a thesis committee. The PIs in the InfBio RC are members in a total of 
52 thesis committees and 35% of these students are affiliated in the InfBio RC.  
Another way to assure quality of the training is to measure scientific quality of the PhD thesis. Out of the 
39 completed PhDs in 2005-2010 three have been accepted with honors and the average number of 
articles published in international peer-reviewed journals and included in the thesis is high, 4.1 articles 
per thesis.  
The third way of quality assurance is to document if the doctorates have benefitted the training. To 
monitor this, a questionnaire re the position and usefulness of the PhD studies is sent to all the 
doctorates three to five years after completing the PhD studies (starting from doctorates graduated 
2008). 
In addition, a considerable number of foreign students are attracted to our doctoral training as the 
research topics are international and global already in nature (Marie Curie students and students 
supported by international exchange programs). 
 
Career perspectives  
In December 2009 some PIs in the InfBio RC arranged a symposium at Haartman Institute entitled 
“Career opportunities after PhD” with more 100 participants. The broad international networks, for 
example the “Network of Excellence” and international programmes advance scientific career contacts 
abroad. Contacts to industry, through funding or collaboration, advance industry career perspectives 
(several PIs in the RC have contacts to industry) and good contacts to the Helsinki Univ. Central Hospital 
and its laboratory HUSLAB advances clinical or diagnostic career perspectives for both PhD and MD/PhD 
doctorates. 
After completing their PhD degrees, most of our PhDs have continued scientific career or published 
articles after the thesis (64%), and approximately half of them have moved abroad to well known 
research groups and institutes indicates that the quality of doctors educated in the RC is very high. 
 RC’s strengths and challenges related to the practises and quality of doctoral training, and the actions 
planned for their development. 
Strengths: The InfBio research groups are led by top class scientists covering broadly the fields of 
microbiology and infection immunology. The community is very active in doctoral training and the 
number of doctoral trainees and post-docs is large enough to provide intra- and intergroup horizontal 
support utilized in meetings, seminar series, and thesis committees. The InfBio RC provides a well 
structured quality assurance scheme for training of the doctoral candidates.   
Challenges: The research funding in the field has been hit by the tight budgets and this affects our ability 
to recruit doctoral candidates. We are good in training PhD students but we need still to put more 
emphasis on broad teaching of techniques both in the wet lab as well as in in silico approaches to give 
tools to solve system level problems of clinically relevant medical problems. Our challenge is also to 
recruit more students with medical background to support study of clinical themes in infectious 
diseases, microbiology, and immunology. 
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 Description of how the RC interacts with and contributes to the society (collaboration with public, 
private and/or 3rd sector).  
InfBio RC is working in an area of strong societal impact and public interest – infection biology and 
infectious diseases. The work concerns infection threats like pandemics, hospital infections, novel 
diagnostics and new vaccines. Our impact on the various sectors involves both immediate help for 
urgent situations as well as long-sighted views to combat problems of the future, like antibiotic 
resistance and the emergence of new microbes.  
The closest cooperation partner to us is the Helsinki University Central Hospital (HUS). The University of 
Helsinki and HUS have defined infections and inflammation as a joint focus area with significant impact 
on the society. Our good tradition in carrying out research within this field puts us into the prime 
position in helping the hospital in its research needs. A dynamic interaction involves our participation in 
the development of innovative diagnostics with the hospital laboratory, HUSLAB, the biggest of its kind 
in Finland (annual budget 160 mill. euros). In fact, we have originally set up most of the diagnostic tests 
used at HUSLAB and continue doing so. In exchange of our know-how the hospital supports us with 
dynamic funding (EVO) for individual high quality research projects and for some daily needs. In turn, 
new diagnostic tests keep on emerging providing revenue to HUSLAB. The collaboration with the 
hospital involves also training of medical doctors (MD and MD/PhD) as well as of specialists in Clinical 
Microbiology, who all will have an opportunity to serve jointly at the University of Helsinki and HUS to 
observe the diagnostics and treatment of patients with infections and immunoinflammatory syndromes.  
We also collaborate with the Public Health Institute (THL), the Finnish Red Cross Blood transfusion 
service and provide expert help to ministries e.g. in questions of infections, food safety, biosafety and 
defence. Occasionally this concerns new European Union legislation and directives (for example, we can 
buy fresh salmon without the need to freeze it for 24 hours before use!). 
Our research area is of great interest to the private sector. We have many links to companies developing 
diagnostics, vaccines and new therapeutics. For example, there are ongoing projects with Novartis (new 
meningococcal vaccines) and GSK (pneumococcal vaccines). Our PIs have developed innovative 
diagnostics. Klaus Hedman became famous for inventing the “avidity” concept, which is now used in a 
vast number of serological tests around the world. Antti Vaheri developed a practical test for diagnosing 
the Puumala hantavirus-infection. We have founded start-up companies (e.g. NextMed and 
Complementum) and filed many patents in our field. Overall, we are continuing attempts to expand to 
this direction, which has great potential. At the same time, however, we need to carefully keep the 
balance and draw lines between free academic research and services to the private sector. 
The public is kept informed by appearances in newspaper, journal, radio and TV interviews. We also 
actively write educational articles to the health personnel and to  the general public. We were strongly 
involved in the writing and editing of a large and brand new 3-volume textbook on Clinical Microbiology, 
Immunology and Infectious Diseases. 
 Ways to strengthen the societal impact of the RC’s research and doctoral training. 
1. We still need to put more effort on the most common and/or severe diseases and try to find novel 
diagnostic and treatment modalities for them.  
2. It is essential that we continue and develop further the fruitful and productive collaboration with 
HUSLAB. 
3. An essential constituent of our work is to develop further collaboration with commercial (diagnostic; 
pharmaceutical) biomanufacturers.  
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4. In Finland the standards of PhD training have traditionally been very high. We can act as an example 
and help setting standards at the European level to generate a common “academic currency” of know-
how. This involves improving the quality of PhD training in graduate schools. The benefits would include  
higher level training and increased mobility of PhD students and postdocs across Europe and elsewhere.  
5. Researchers with the latest and most reliable information need to go more to the public and clarify 
common misconceptions and misinformation that appears to be spreading increasingly in different 
forms of media. For this, novel technology should be better exploited. 
 
 
 
 Description of the RC’s research collaborations and joint doctoral training activities and how the RC 
has promoted researcher mobility.  
The InfBio RC made a survey of significant collaborations among its 12 groups. 
The groups have had collaboration to groups active on five continents. Altogether 238 major 
international and domestic major collaborators were identified. These activities have been clearly 
documented as joint publications. The survey identified 518 collaborative publications (subject to minor 
inaccuracies since it was not cross-checked for overlaps and missing data) indicating most active 
collaboration with Finnish partners, altogether 298 joint publications, followed by Germany 57, Sweden 
51, USA 27, Italy 12, UK 10, China 10, Russia 7 and Australia 6. Other countries with active collaborations 
but fewer publications were Austria (1), Belgium (4), Brazil (0), Bulgaria (1), Canada (2), Croatia (2), 
Denmark (2), Ghana (1), France (4), Hungary (2), Indonesia (3), Japan (1), Mali (1), Netherlands (3), 
Norway (1), Poland (3), Slovenia (4), Spain (4)  and Turkey (1). 
In addition to medical, molecular biology, virology, bacteriology, immunology, and biochemistry 
collaborations the InfBio RC research activities are complemented with collaborations with clinicians, 
epidemiologists, structural biologists, organic chemists, structural chemists and bioinformaticians and 
biostatisticians.  
The InfBio RC groups reported 43 collaborations that included joint doctoral training activities. This has 
been organized both as a co-supervision of doctoral students in Finnish and international universities 
such that either the InfBio RC PI has co-supervised abroad or collaborative group PI in Finland.  
The InfBio RC PIs participate in several EU consortia, and are also actively involved in training networks 
such as Sokrates/Erasmus and Marie Curie activities. 
Researcher mobility has been promoted by organizing mutual PhD candidate exchange, also a number 
of PIs have made both teaching and research visits to several collaborating countries. For example, S. 
Jokiranta has been a teacher in European Complement Network teaching days (2007 in Cardiff, UK and 
2009 in Visegrad, Hungary) meant for PhD candidates and young post-docs, and M. Skurnik has active 
Sokrates/Erasmus exchange with University of Silesia, Poland, with annual teaching weeks in Katowice. 
T. Korhonen, S. Meri, M. Skurnik and B. Westerlund-Wikström were partners in EU Network of 
Excellence on EuroPathoGenomics and actively participated in PhD training courses. S. Meri is the 
current Secretary General of IUIS, the umbrella organization of all immunologists (30 000 members). In 
this role he has participated in the organization and teaching in a number of immunology courses, e.g. in 
Denmark, Egypt, France, Croatia, Italy and Taiwan. 
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 RC’s strengths and challenges related to research collaboration and researcher mobility, and the 
actions planned for their development. 
The InfBio RC has already now very strong collaborative networks world-wide and domestically as 
evidenced by the above summary. In Europe, for example, most active international collaboration takes 
place with Germany and Sweden that are in the forefront in infection biology research and this activity 
will be continued. In our opinion we should increase collaboration to UK, France and Switzerland.  
One fruitful avenue that we would like to exploit is organizing joint doctoral training courses with 
infection biology graduate schools of other European countries. One such joint course where our 
doctoral students can participate will be organized this spring with Karolinska Institute in Stockholm.  
To get an active start-up for visiting scientists we would like to arrange a training package upon arrival. 
This includes basic information about available facilities and training, when relevant, in animal 
experimentation safety, handling of microbes and radioactive substances. 
 
 
 Description of the operational conditions in the RC’s research environment (e.g. research 
infrastructure, balance between research and teaching duties).  
Most of the RC is housed in the Haartman Institute (www.hi.helsinki.fi) at the Meilahti campus, while 
2/12 of its principal investigators work at the Viikki campus. The core of the Meilahti part of the RC is 
formed by research groups belonging to the Infection Biology Program, one of the 6 research programs 
of the Faculty of Medicine that were established in 2007 based on a competitive evaluation carried out 
by an eminent group of international experts. 
Juxtaposed across the street Haartmaninkatu is Finland's largest clinical hospital (Helsinki University 
Central Hospital), and the largest academic research site (Biomedicum), and the Nordic EMBL 
Partnership Institute the Institute for Molecular Medicine Finland (www.fimm.fi). This location provides 
our RC an access to the most modern biomedical research infrastructure and equipment in Finland and 
an ideal environment for reaching its goal, namely translational research of highest international level. 
The Viikki campus is another national hotbed of biomedical research infrastructure and high quality 
research. Specifically, Viikki campus has excellent facilities for protein chemistry, proteomics, genomics, 
and image analysis. Thus, all groups within our RC enjoy excellent operational conditions and a world-
class research environment.  
Meilahti and Viikki campuses both have large and well-organised graduate schools providing education 
and training in relevant fields of research for our RC.    
All groups in our RC are actively engaged in basic and postgraduate education in different fields of 
immunology and microbiology. Compared to research groups with similar scientific impact, the burden 
of teaching of most of the principal investigators in our RC is rather high. However, this strong 
involvement in teaching and interaction with students is also an important asset to our RC.  
The RC research groups collaborate actively with each other. This active internal collaboration will be 
further invigorated, which is expected to amplify the positive development of both quality and quantity 
of science carried out in our RC, as well as to compensate for relative weaknesses of different parts of 
our RC. For example, while the Viikki campus has been notably strong in molecular bacteriology, genetic 
biotechnology for e.g. diagnostics and probiotics, and bacteria-human interactions, its microbiology 
research has suffered from poor contacts to hospitals and clinical/medical microbiologists. On the other 
hand, the latter aspect is one of the clear strengths of RC laboratories at the Meilahti campus. 
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 RC’s strengths and challenges related to operational conditions, and the actions planned for their 
development. 
Our RC provides excellent synergy among high quality research groups working on interrelated topics. 
Further collaborations will be established with clinicians and diagnostic labs.  
The most obvious challenges and threats related to operational conditions of our RC are financial. 
Especially in the Haartman Institute the budgetary problems are severe, seriously threatening the 
scientific productivity of our RC, and risking its research groups to consider offers from better-resourced 
institutions. Currently all research costs must be covered by external grant support, which during the 
recent years has decreased rather than increased. In this environment the development of new research 
groups into established excellence is very difficult, which could have catastrophical consequences in 10-
20 years. The lack of institutional support is also evident as gradual decline of all mid-size research 
equipment and localised research infrastructure that is overlooked by competitive research 
infrastructural investment programs, but yet too expensive to be covered by individual research grants. 
 
 
 
 Description of the execution and processes of leadership in the RC, how the management-related 
responsibilities and roles are distributed in the RC and how the leadership- and management-related 
processes support high quality research, collaboration between principal investigators and other 
researchers in the RC, the RC’s research focus and strengthening of the RC’s know-how.  
The InfBio RC has a nominated leader (Seppo Meri), a Vice leader (Kalle Saksela) and a coordinator (Tarja 
Sironen), but in general the organisation has a low level of hierarchy and is based on scientific 
collaboration. The consortium includes 1 groups with PIs and altogether 112 researchers. Of the PIs 7 
represent professor-led member groups (KH, SM, AP, RR, KS, MS, AV) from the Haartman Institute, the 
Faculty of Medicine and 5 others represent groups led by younger PIs (SJ, MP, MSV) or groups from the 
Faculty of Biosciences (TK, BWW). Although there is partial overlap, the Faculty (Risto Renkonen, the 
Dean) and the Haartman Institute (Seppo Meri, the Head) administrations are kept separate from the 
InfBio RC.  
Distribution of responsibilities. It is the responsibility of the leader, together with the coordinator, to 
keep the groups informed and gather PI:s together for regular and ad-hoc meetings. Regularly we have 
1-2 meetings/year plus another 1-2 meetings on the occasions of the annual InfBio days. Each PI is 
subsequently responsible for managing their own research groups. 
Training duties and core-facilities. Mikael Skurnik is involved in training of Hospital Microbiologists 
(MSc), Seppo Meri is supervising specialist training of Clinical Microbiologists (MDs) and Timo Korhonen 
of General Microbiologists (MSc). Microbial safety issues are handled in each group by nominated 
individuals. Sakari Jokiranta is in charge of radioactive safety and holds examinations to anyone 
embarking on work involving radioactivity. Alexander Plyusnin is coordinating Infection Biology teaching 
at the Faculty’s Translational Medicine program (TransMed). Additional core facilities include   the BSL3 
biosafety facility, a sequencing lab, peptide-Biacore unit, mass spectrometry facility and a maintenance 
unit.  
Small amounts of Institute funding and so called EVO-funding (from the hospital, approximately 350 000 
euros/year) are shared on the basis of scientific achievements during the past 3 years (quality and 
number of publications and dissertations).  
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Strengthening know-how. The administrative activities of the InfBio RC support high quality research by 
ensuring spread of information, brainstorming ideas during the meetings, providing research facilities 
and boosting collaboration.  
InfBio is very active in training students and clinicians. We organise courses, symposia and weekly 
Haartman seminars (focusing on basic science) and participate in monthly “Clinfection” meetings. 
Regular InfBio activities include annual Microbial pathogenesis days (organised by Mikael Skurnik) and 
InfBio Days twice a year. We (Sakari Jokiranta in particular) have also been involved in organising video 
courses with participants from all over Finland (approximately 700 in a course on International Health in 
2010). Currently we are running a course on Parasitology and Tropical Diseases, which is transmitted live 
to 18 different centers and hospitals in Finland). 
Our students participate actively in scientific meetings of their own fields. We also encourage visits 
between laboratories and abroad. Some of the most fruitful achievements have emerged from students 
who have worked in different InfBio member laboratories. 
 RC’s strengths and challenges related to leadership and management, and the actions planned for 
developing the processes. 
Strengths 
1. The expertise profiles of the Infection Biology RC PI’s are synergistic. The research area is central to 
human well-being and motivating both to group leaders and members. This makes it easy and 
straightforward to lead the RC.  
2. The close contacts to the hospital laboratory HUSLAB provide synergy for management by broadening 
the operational basis. 
3. In the InfBio RC the different research groups provide their special expertise for other researchers. 
There is good cohesion, a positive spirit and sufficient critical mass. 
 
Challenges  
1. The InfBio groups feel somewhat isolated from the Research Programs of the Medical Faculty, which 
constitute a separate administrative unit. 
2. There has not been any financial support to the InfBio RC, neither space nor other resources, from the 
University of Helsinki.  
 
Actions  
1. The RC hopes to get its own funding to be able to set strategic goals.  
2. In future the tasks of the leader and coordinator could be rotated.  
3. The InfBio RC has an active website but it could be further developed into an administrative tool. 
 
 
 
 Listing of the RCs external competitive funding, where: 
- the funding decisions have been made during 1.1.2005-31.12.2010, and 
- the administrator of the funding is/has been the University of Helsinki 
 
 Academy of Finland (AF) - total amount of funding (in euros) AF has decided to allocate to the RC 
members during 1.1.2005-31.12.2010: 7890000 
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 Finnish Funding Agency for Technology and Innovation (TEKES) - total amount of funding (in euros) 
TEKES has decided to allocate to the RC members during 1.1.2005-31.12.2010: 1140000 
 
 European Union (EU) - total amount of funding (in euros) EU has decided to allocate to the RC members 
during 1.1.2005-31.12.2010: 1120000 
 
 European Research Council (ERC) - total amount of funding (in euros) ERC has decided to allocate to the 
RC members during 1.1.2005-31.12.2010:  
 
 International and national foundations – names of international and national foundations which have 
decided to allocate funding to the RC members during 1.1.2005-31.12.2010, and the amount of their 
funding (in euros).  
- names of the foundations: Finnish Cancer organization 
- Magnus Ehrnrooth Foundation 
- Sigrid Juselius 
- Runar Bäckström foundation 
- total amount of funding (in euros) from the above-mentioned foundations: 1960000 
 
 Other international funding - names of other international funding organizations which have decided to 
allocate funding to the RC members during 1.1.2005-31.12.2010, and the amount of their funding (in 
euros). 
- names of the funding organizations: CIMO 
- NIH 
- total amount of funding (in euros) from the above-mentioned funding organizations: 300000 
 
 Other national funding (incl. EVO funding and Ministry of Education and Culture funded doctoral 
programme positions) - names of other national funding organizations which have decided to allocate 
funding to the RC members during 1.1.2005-31.12.2010, and the amount of their funding (in euros). 
- names of the funding organizations: HUSLAB, R&D 
- Sotilaslääketieteen keskus 
- MATINE 
- EVO 
- University of Helsinki 
- Biocentrum Helsinki 
- HBGS student salary 
- Valio 
- M&M ministeriö 
- Turun yliopisto 
- FLS 
- total amount of funding (in euros) from the above-mentioned funding organizations: 3390000 
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 Description of the RC’s future perspectives in respect to research and doctoral training. 
The main strategy of the InfBio RC will be to continue top level studies focusing on microbe-host 
interactions. Studies until now have proven fruitful and lay the basis for continuing productive research. 
Collaboration between the two campuses (Viikki and Meilahti) will be further increased. Studies will be 
carried out on the roles that microbes play in causing, promoting or even protecting from disease. On 
the other hand, we will address new possibilities to determine individual susceptibility to infections and 
immunoinflammatory diseases. This will be done both within our RC and in collaboration with clinicians, 
geneticists and people in charge of high throughput analytical methods (e.g. at FIMM). Another strategic 
line is to increase collaboration with the Public Health Institute (THL) e.g. in studies related to vaccines, 
adjuvants and their potential side effects.  
The strategy is based on new possibilities to prevent disease that emerge from increased understanding 
of the pathogenesis and course of infectious diseases. The fact that sequencing  of bacterial, fungal and 
viral genomes has become affordable will allow us to identify virulence factors, their interaction 
partners and interactions. Technical advances have made it possible to study interactions biophysically 
through structures and single molecule techniques. With the help of animal models the roles of 
virulence factors and disease susceptibility determinants can also be determined. Our future studies will 
thus aim at the development of new diagnostics, therapies, vaccines and other preventive measures.  
 
The specific aims can be summarised as the following: 
1) recognition of microbial virulence factors  
2) structural analysis of virulence factors and their mechanisms of action  
3) role of virulence factors in species- and cell type-specificity of microbial infections 4) large scale 
analysis of molecular interactions in microbial virulence  
5) search for inhibitors of virulence factors and their utilisation as vaccine candidates 6) development of 
innovative diagnostics  
7) determine reasons for individual susceptibility to infections  
8) analyse the role of microbes in promoting immunoinflammatory diseases 
 
Doctoral training 
Our strategic goals in improving doctoral training include the following: 
1) Recruit to get the best and most motivated students.  
2) Although we currently have fairly rigorous training and monitoring systems there is always a 
possibility to improve training and education in animal experimentation, microbial safety and handling 
of chemicals and radioactive substances. 
3) Increase training in joint courses and symposia. This concerns especially genetics, high throughput 
methods, epidemiology, information biology, medical training to nonmedics, research ethics and 
presentation skills. 
4) Rotation of students in different laboratories, in at least two, to increase synergy and spreading the 
best practices. This involves student exchange between the Viikki and Meilahti campuses. 
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5) Increase collaboration with clinicians working with patients having infectious or immunoinflammatory 
diseases. First hand information from clinicians is very important in finding clues to disease pathogenesis 
(predisposing factors, causative organisms, mechanisms of complications or postinfective sequelae). 
6) Set up a graduate School in Infection Biology.  
7) Increase national and international collaboration, particularly at the European level. 
8) Increase awareness of the problems and risks that infectious diseases and inappropriate use of 
antibiotics pose in the future. This concerns also decision makers. At the moment, research funding in 
this area is not adequate enough. 
 
We will continue participation in the development of PhD training in biomedical sciences both nationally 
and internationally. Emphasis will be based on setting up training via the internet by creating discussion 
groups and other web-based learning tools. This will provide a national centre for profound 
understanding of microbial virulence and be a collaboration partner for public institutions concerned 
with infectious diseases and for pharmaceutical companies in the development of new vaccines and 
drugs to combat infectious and inflammatory diseases. 
 
 
 
Each member (PI) of the InfBio RC contributed their own data into the stage 2 evaluation, whereafter 
the final version was compiled together by Seppo Meri.  
 
Specific forms were generated for accurate data collection on doctoral training (point 2), researcher 
mobility (point 4) and finances (point 7). Therefore the specific data on these points is available if 
needed during the evaluation. Information on Doctoral training (point 2) was merged together by Sakari 
Jokiranta and Mirja Puolakkainen. Data for research collaboration and researcher mobility was gathered 
by Mikael Skurnik (point 4), and on finances (point 7) by the coordinator Tarja Sironen. Kalle Saksela 
collected and merged together information on operational conditions (point 5). Special effort for data 
collection was needed because of the large size of the research consortium and the need for accuracy. 
 
Each member contributed significantly, so we do not need to keep anyone behind the curtains during 
the actual evaluation. 
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1 Analysis of publications 
 
- Associated person is one of Antti Vaheri ,  Jussi Matias Hepojoki ,  Eili Anna Huhtamo ,  
Anne J Jääskeläinen ,  Anu Jääskeläinen ,  Suvi Kuivanen ,  Satu Kurkela , 
 Erika Lindh ,  Niina Johanna Putkuri , Pertteli Salmenperä ,  
Jussi Sane ,  Tarja Anita Sironen ,  Tomas Strandin ,  Elina Tonteri ,  
Hao Wang , Anna Enzerink , Walter Johannes Koskinen ,  Kati Anneli Räsänen , 
 Aleksandr Pljusnin ,  Agne Alminaite ,  Anna Rosa Maria Katz , 
 Maria Razzauti Sanfeliu ,  Kirsi Maria Jääskeläinen ,  Mikael Skurnik , 
 Laura Mattinen ,  Saara Maria Salmenlinna, Heidi Hyytiäinen ,  Chun Mei Li , 
 Neeta Sengupta , Saija Johanna Kiljunen, Elise Marleena Pinta ,  Zhilin Li ,  Tea 
Susanna Blom ,  Marta Biedzka-Sarek, Seppo Meri ,  Hanna Jarva , Tobias Freitag , 
 Nathalie Friberg ,  Derek Ho ,  Ville Holmberg ,  Ayman Khattab , 
Antti Lavikainen ,  Inkeri Lokki ,  Rauna Riva ,  Jorma Tissari , 
 T. Sakari Jokiranta ,  ,  Taru Susanna Meri , Markus Juhana 
Lehtinen ,  Karita Haapasalo ,  Aino Koskinen ,  Arnab Bhattacharjee , 
 ,  Hanne Amdahl ,  Satu Hyvärinen ,  Mirja 
Puolakkainen ,  Eveliina Markkula ,  Laura Elisabeth Mannonen ,  Suvi Niemi 
,  Jaakko Aarne Johannes Hulkkonen ,  Risto Renkonen ,  Pirkko Maria Mattila , 
 Jutta Anneli Renkonen ,  Kalle Saksela ,  Annika Järviluoma , 
 Arunas Kazlauskas ,  Tapio Kesti ,  Iivari Kleino ,  Sergio 
Lavilla Alonso ,  Constanze Schmotz ,  Erkko Ylösmäki ,  Leena Ylösmäki , 
Kristina Zumer ,  Klaus Hedman ,  Maria Söderlund-Venermo , Maria.Soderlund-
 Rauli Mikael Franssila ,  Tingting Chen , Kalle Kantola ,  Arun 
Kumar , Mohammad Sadeghi ,  Päivi Hannele Norja ,  Elina Väisänen , 
Claudia Filippone, Sanna Maria Aalto ,  Kati Christel Hokynar , Laura Kakkola , 
 Benita Westerlund-Wikström ,  Lena Marina Anton ,  Sanna Kylväjä , 
 Timo Antero Lehti ,  Timo Korhonen ,  Ritva Virkola ,  Katri Mari 
Juuti ,  Sanna Edelman, Jenni Antikainen ,  Johanna Haiko , Veera Kuparinen , 
Marjo Suomalainen ,  
 
Publication year 
Publication type 2005 2006 2007 2008 2009 2010 
Total Count 2005 - 
2010 
A1 Refereed journal article 55 64 69 93 71 75 427 
A2 Review in scientific journal 2 3 4 1 5 2 17 
A3 Contribution to book/other compilations (refereed) 9 11 3 16 6  45 
A4 Article in conference publication (refereed) 1 3 1 2 1 4 12 
B1 Unrefereed journal article 9 3 3 4 3 3 25 
B2 Contribution to book/other compilations (non-refereed)  1   1 1 3 
C1 Published scientific monograph    1   1 
D1 Article in professional journal  2 2 2 4 7 17 
D2 Article in professional hand or guide book or in a professional data 
system, or text book material 
     17 17 
E1 Popular contribution to book/other compilations      1 1 
H1 Patents   1 1  1 3 
I1 Audiovisual materials     1  1 
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2 Listing of publications 
A1 Refereed journal article 
2005 
Alhopuro, P, Ylisaukko-oja, S, Koskinen, W, Bono, P, Arola, J, Järvinen, HJ, Mecklin, J, Atula, T, Kontio, R, Mäkitie, A, Suominen, S, 
Leivo, I, Vahteristo, P, Aaltonen, L, Aaltonen, LA, Suominen, S 2005, 'The MDM2 promoter polymorphism SNP309T-->G and the risk of 
uterine leiomyosarcoma, colorectal cancer, and squamous cell carcinoma of the head and neck', Journal of Medical Genetics, vol 42, 
no. 9, pp. 694-698. 
Alitalo, A, Meri, T, Comstedt, P, Jefferey, L, Tornberg, J, Strandin, T, Lankinen, H, Bergström, S, Cinco, M, Vuppala, SR, Akins, DR, 
Meri, S 2005, 'Expression of complement factor H binding immunoevasion proteins in Borrelia garinii isolated from patients with 
neuroborreliosis', European Journal of Immunology, vol 35, no. 10, pp. 3043-3053. 
Appel, GB, Cook, HT, Hageman, G, Jennette, JC, Kashgarian, M, Kirschfink, M, Lambris, JD, Lanning, LD, Lutz, HU, Meri, S, Rose, NR, 
Salant, DJ, Sethi, S, Smith, RJ, Smoyer, W, Tully, HF, Tully, SP, Walker, PD, Welsh, M, Wurzner, R, Zipfel, PF 2005, 
'Membranoproliferative glomerulonephritis type II (dense deposit disease): an update',  Journal of the American Society of 
Nephrology, vol 16, no. 5, pp. 1392-1404. 
Bhattacharjee, A, Bansal, M 2005, 'Collagen structure: The Madras triple helix and the current scenario', IUBMB Life, vol 57, pp. 161-
172. 
Biedzka-Sarek, M, Venho, R, Skurnik, M 2005, 'Role of YadA, Ail, and Lipopolysaccharide in Serum Resistance of Yersinia 
enterocolitica Serotype O:3', Infection and Immunity, vol 73, no. 4, pp. 2232-2244. 
Bjørge, L, Hakulinen, J, Vintermyr, OK, Jarva, H, Jensen, TS, Iversen, OE, Meri, S 2005, 'Ascitic complement system in ovarian cancer', 
British Journal of Cancer, vol 92, no. 5, pp. 895-905. 
Brader, G, Sjöblom, S, Hyytiäinen, H, Sims-Huopaniemi, K, Palva, ET 2005, 'Altering substrate chain length specificity of an 
acylhomoserine lactone synthase in bacterial communication', Journal of Biological Chemistry, vol 280, no. 11, pp. 10403-10409. 
Brooks, CS, Vuppala, SR, Jett, AM, Alitalo, A, Meri, S, Akins, DR 2005, 'Complement regulator-acquiring surface protein 1 imparts 
resistance to human serum in Borrelia burgdorferi', Journal of Immunology, vol 175, no. 5, pp. 3299-3308. 
Chen, R, Sehr, P, Waterboer, T, Leivo, I, Pawlita, M, Vaheri, A, Aaltonen, L 2005, 'Presence of DNA of human papillomavirus 16 but no 
other types in tumor-free tonsillar tissue', Journal of Clinical Microbiology, vol 43, no. 3, pp. 1408-1410. 
Cheng, Z, Corey, MJ, Pärepalo, M, Majno, S, Hellwage, J, Zipfel, PF, Kinders, RJ, Raitanen, M, Meri, S, Jokiranta, S 2005, 
'Complement factor H as a marker for detection of bladder cancer', Clinical Chemistry (Washington, DC), vol 51, no. 5, pp. 856-863. 
Chia, YS, Badaut, C, Ndam, NGT, Khattab, A, Igonet, S, Fievet, N, Bentley, GA, Deloron, P, Klinkert, MQ 2005, 'Functional and 
immunological characterization of a Duffy binding-like-gamma domain from Plasmodium falciparum erythrocyte membrane protein-1 
expressed by a placental isolate', Journal of Infectious Diseases, vol 192, pp. 1284-1293. 
Cvetko, L, Marcotic, A, Plyusnina, A, Margaletic, J, Miletic-Medved, M, Turk, N, Milas, Z, Avsic-Zupanc, T, Pljusnin, A 2005, 'Puumala 
virus in Croatia in the 2002 HFRS outbreak', Journal of Medical Virology, vol 77, no. 2, pp. 290-294. 
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potilasnäytteiden mikrobiologiset tutkimukset, Kansanterveyslaitoksen julkaisujaC, no. 1/2008, Kansanterveyslaitos, Helsinki. 
D1 Article in professional journal 
2006 
Jokiranta, S, Hautala, T 2006, 'Syyhy', Takiainen., vol 2006, no. 1, pp. 4-9. 
Jokiranta, S 2006, 'Kihomatodiagnostiikka', Moodi., vol 30, no. 1, pp. 66-67. 
2007 
Jokiranta, S, Hautala, T 2007, 'Vaatetäi', Takiainen., vol 2007, no. 1, pp. 18-22. 
Vapalahti, O, Jokiranta, S, Brummer-Korvenkontio, H 2007, 'Hyönteisten ja puutiaisten välittämät taudit matkailijoilla', Kansanterveys : 
Kansanterveyslaitoksen tiedotuslehti. , vol 2007, no. 2, pp. 8 - 9. 
2008 
Jokiranta, S, Hautala, T 2008, 'Satiainen', Takiainen., vol 2008, no. 1, pp. 10-16. 
Jokiranta, S 2008, 'Päivystysaikaiset pikadiagnostiset tutkimukset: malaria', Moodi., vol 30, no. 1, pp. 31. 
2009 
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Asikainen, M, Hautala, T, Huusko, S, Häkkinen, P, Jokiranta, S, Kotilainen, H, Mikander, H, Nieminen, T, Salo, E, Valtonen, K, 
Kansallinen päätäiasiantuntijaryhmä 2009, 'Ohjeet päätäitartunnan toteamiseksi ja hoidoksi', Takiainen., no. 1, pp. 13-15. 
Jokiranta, S 2009, 'Keliakiatutkimukset', Yksityislääkäri, no. 2, pp. 64-65. 
Meri, T, Jokiranta, S 2009, 'Malariadiagnostiikka ja pikadiagnostiikka: [luentolyhennelmä: Labquality päivät 4.2.2009]',  Moodi., no. 1, pp. 
28-29. 
Meri, S, Jokiranta, TS, Meri, TS, Alitalo, R 2009, 'Malariadiagnostiikka päivystystilanteissa (Diagnostics of malaria)',  Moodi., vol 2009, 
no. 5, pp. 259-262. 
2010 
Hiltunen-Back, E, Alanen, A, Heikkilä, E, Puolakkainen, M, Reunala, T, Suni, JI, Suomalainen, P, Valtonen, K, Varis, T, Vuento, R 2010, 
'Käypä hoito suositus: Sukupuolitautien diagnostiikka ja hoito', Duodecim, vol 129, no. 17, pp. 2077-2078. 
Jokiranta, TS 2010, 'Suolistomatojen diagnostiikka', Moodi., vol 2010, no. 1, pp. 30-31. 
Jokiranta, TS 2010, 'Suolistomadot', Moodi., vol 2010, no. 1, pp. 27-28. 
Jokiranta, TS 2010, 'Lapamato', Moodi., vol 2010, no. 1, pp. 28-29. 
Jääskeläinen, A, Vapalahti, OP 2010, 'Puutiaisaivokuumevirus', Moodi., vol 34, no. 2, pp. 112-115. 
Kere, J, Meri, S, Suomalainen Wartiovaara, A 2010, 'Molekyyligenetiikan huima neljännesvuosisata (Two decades of molecular 
genetics)', Duodecim, vol 126, no. 19, pp. 2297-2299. 
Vaheri, A 2010, 'Fästingen - ett hot i naturen', Sphinx, vol 2009-2010, pp. 15-19. 
D2 Article in professional hand or guide book or in a professional data system, or text book 
material 
2010 
Bamford, D, Hyypiä, T, Saksela, K 2010, 'Virusten ominaisuudet, rakenne ja luokittelu', in P Huovinen, K Hedman, T Heikkinen, A 
Järvinen, S Meri, M Vaara (eds), Mikrobiologia, Kustannus Oy Duodecim, pp. 449-459. 
Davidkin, I, Hedman, K 2010, 'Vihurirokkovirus', in K Hedman, T Heikkinen, P Huovinen, A Järvinen, S Meri, M Vaara (eds) , 
Mikrobiologia: Mikrobiologia, immunologia ja infektiosairaudet, kirja 1, 1 edn, vol. 2010, Kustannus Oy Duodecim, Helsinki, pp. 
508-511. 
Hukkanen, V, Saksela, K, Hyöty, H 2010, 'Virusinfektioiden patogeneesi', in P Huovinen, K Hedman, T Heikkinen, A Järvinen, S Meri, M 
Vaara (eds), Mikrobiologia, Kustannus Oy Duodecim, pp. 432-448. 
Hyypiä, T, Ahola, T, Söderlund-Venermo, AM 2010, 'Virusten lisääntyminen', in P Huovinen, K Hedman, T Heikkinen, A Järvinen, S 
Meri, M Vaara (eds), Mikrobiologia . mikrobiologia, immunologia ja infektiosairaudet, Kirja 1., vol. 2010, Duodecim, Helsinki, pp. 
460-469. 
Jokiranta, TS, Salo, E 2010, 'Niveljalkaiset: Täit, Syyhy, Myiaasi, Kirput, Muut ihmistä vaivaavat niveljalkaiset', Mikrobiologia 1, 
Duodecim, Helsinki. 
Jokiranta, TS, Ristola, MA 2010, 'Muut parasiitit', Mikrobiologia 1, 1 edn, Duodecim, Helsinki. 
Jokiranta, TS, Siikamäki, HM, Meri, S 2010, 'Madot (Worms)', Mikrobiologia. mikrobiologia, immunologia ja infektiosairaudet, kirja 
1 ., Kustannus Oy Duodecim. 
Meri, S, Jokiranta, TS 2010, 'Mikä tekee parasiitista patogeenin? (What makes parasite a pathogen?)',  Mikrobiologia. mikrobiologia, 
immunologia ja infektiosairaudet, kirja 1., 1 edn, Duodecim, Helsinki. 
Oksanen, A, Lavikainen, A, Näreaho, AS, Isomursu, M 2010, 'Loiset', in S Hallanvuo, TJ (eds), Elintarvikkeiden mikrobiologiset 
vaarat, Eviran julkaisuja , no. 1/2010, Evira, Helsinki, pp. 135-196. 
Siikamäki, HM, Jokiranta, TS, Meri, S 2010, 'Alkueläimet (Protozoa)', Mikrobiologia. mikrobiologia, immunologia ja 
infektiosairaudet, kirja 1., Kustannus Oy Duodecim. 
Skurnik, M 2010, 'Bakteerigenetiikka', in P Huovinen, K Hedman, T Heikkinen, A Järvinen, S Meri, M Vaara (eds) , Mikrobiologia ja 
infektiosairaudet. Kirja 2., Kustannus Oy Duodecim, pp. 41-55. 
Suni, JI, Saksela, K, Ristola, MA 2010, 'Ihmisen immuunikatovirukset', in P Huovinen, K Hedman, T Heikkinen, A Järvinen, S Meri, M 
Vaara (eds), Mikrobiologia, Kustannus Oy Duodecim, pp. 640-668. 
Söderlund-Venermo, AM, Hedman, K 2010, 'Parvovirukset ja muut yksisäie-DNA-virukset', in P Huovinen, K Hedman, T Heikkinen, A 
Järvinen, S Meri, M Vaara (eds), Mikrobiologia. mikrobiologia, immunologia ja infektiosairaudet, kirja 1., Kustannus Oy 
Duodecim, Helsinki, pp. 632-639. 
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Vaara, M, Skurnik, M, Sarvas, M 2010, 'Bakteerisolun rakenne ja toiminta', in P Huovinen, K Hedman, T Heikkinen, A Järvinen, S Meri, 
M Vaara (eds), Mikrobiologia ja infektiosairaudet. Kirja 2., Kustannus Oy Duodecim, pp. 14-40. 
Vaheri, A, Pljusnin, A 2010, 'Virusten ja virustautien evoluutio', in K Hedman et al. (ed.), Mikrobiologia. mikrobiologia, immunologia 
ja infektiosairaudet. kirja 1., Kustannus Oy Duodecim, Helsinki, pp. 716-719. 
Vaheri, A, Ojala, P 2010, 'Virukset ja syöpä', in K Hedman et al. (ed.), Mikrobiologia. mikrobiologia, immunologia ja 
infektiosairaudet. kirja 1., Kustannus Oy Duodecim, Helsinki, pp. 689-697. 
Vapalahti, OP, Vaheri, A 2010, 'Zoonoosi- ja arbovirukset', in K Hedman et al. (ed.), Mikrobiologia. mikrobiologia, immunologia ja 
infektiosairaudet. kirja 1., Kustannus Oy Duodecim, pp. 604-630. 
E1 Popular contribution to book/other compilations 
2010 
Meri, S 2010, 'Lääketieteen tutkija kirjaston käyttäjänä', in K Sinikara, M Forsman, I Karppinen, P Lammi (eds), Rajapinnassa. uusi 
Helsingin yliopiston kirjasto ., Helsingin yliopiston kirjasto, Helsinki, pp. 65-72. 
H1 Patents 
2007 
Nikkari, S, Skottman, T, Skurnik, M Jun. 13 2007, Diagnostic method and products useful therein, EP1795614. 
2008 
Harjula, A, Kankuri, EM, Bizik, J, Vaheri, A 2008, Activated fibroblasts for treating tissue and/or organ damage, WO/2008/020119. 
2010 
Jaatinen, T, Meri, S, Junnikkala, S, Laine, J, Partanen, J Jun. 30 2010, Menetelmä solujen suojaamiseksi (Method of protecting cells), 
FI121073. 
I1 Audiovisual materials 
2009 
Ohjeet päätäitartunnan toteamiseksi ja hoidoksi 
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1 Analysis of activities 2005-2010 
Associated person is one of Antti Vaheri ,  Jussi Matias Hepojoki ,  Eili Anna Huhtamo ,  Anne 
J Jääskeläinen ,  Anu Jääskeläinen , Suvi Kuivanen ,  Satu Kurkela , 
 Erika Lindh ,  Niina Johanna Putkuri , Pertteli Salmenperä ,  
Jussi Sane ,  Tarja Anita Sironen ,  Tomas Strandin ,  Elina Tonteri ,  
Hao Wang , Anna Enzerink , Walter Johannes Koskinen ,  Kati Anneli Räsänen , 
 Aleksandr Pljusnin ,  Agne Alminaite ,  Anna Rosa Maria Katz , 
 Maria Razzauti Sanfeliu ,  Kirsi Maria Jääskeläinen ,  Mikael Skurnik , 
 Laura Mattinen ,  Saara Maria Salmenlinna, Heidi Hyytiäinen ,  Chun Mei Li , 
 Neeta Sengupta , Saija Johanna Kiljunen, Elise Marleena Pinta ,  Zhilin Li ,  Tea 
Susanna Blom ,  Marta Biedzka-Sarek, Seppo Meri ,  Hanna Jarva , Tobias Freitag , 
 Nathalie Friberg ,  Derek Ho ,  Ville Holmberg ,  Ayman Khattab , 
Antti Lavikainen ,  Inkeri Lokki ,  Rauna Riva ,  Jorma Tissari , 
 T. Sakari Jokiranta ,  ,  Taru Susanna Meri , Markus Juhana 
Lehtinen ,  Karita Haapasalo ,  Aino Koskinen ,  Arnab Bhattacharjee , 
 ,  Hanne Amdahl ,  Satu Hyvärinen ,  Mirja 
Puolakkainen ,  Eveliina Markkula ,  Laura Elisabeth Mannonen ,  Suvi Niemi 
,  Jaakko Aarne Johannes Hulkkonen ,  Risto Renkonen ,  Pirkko Maria Mattila , 
 Jutta Anneli Renkonen ,  Kalle Saksela ,  Annika Järviluoma , 
 Arunas Kazlauskas ,  Tapio Kesti ,  Iivari Kleino ,  Sergio 
Lavilla Alonso ,  Constanze Schmotz ,  Erkko Ylösmäki ,  Leena Ylösmäki , 
Kristina Zumer ,  Klaus Hedman ,  Maria Söderlund-Venermo , Maria.Soderlund-
 Rauli Mikael Franssila ,  Tingting Chen , Kalle Kantola ,  Arun 
Kumar , Mohammad Sadeghi ,  Päivi Hannele Norja ,  Elina Väisänen , 
Claudia Filippone, Sanna Maria Aalto ,  Kati Christel Hokynar , Laura Kakkola , 
 Benita Westerlund-Wikström ,  Lena Marina Anton ,  Sanna Kylväjä , 
 Timo Antero Lehti ,  Timo Korhonen ,  Ritva Virkola ,  Katri Mari 
Juuti ,  Sanna Edelman, Jenni Antikainen ,  Johanna Haiko , Veera Kuparinen , 
Marjo Suomalainen ,  
Activity type Count 
Supervisor or co-supervisor of doctoral thesis 64 
Prizes and awards 17 
Editor of research journal 110 
Peer review of manuscripts 162 
Editor of communication journal 1 
Editor of series 4 
Assessment of candidates for academic posts 12 
Membership or other role in review committee 25 
Membership or other role in research network 8 
Membership or other role in national/international committee, council, board 100 
Membership or other role in public Finnish or international organization 43 
Membership or other role of body in private company/organisation 11 
Participation in interview for written media 31 
Participation in radio programme 9 
Participation in TV programme 10 
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Activity type Count 
Participation in interview for web based media 2 
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2 Listing of activities 2005-2010 
Supervisor or co-supervisor of doctoral thesis 
Antti Vaheri ,  
Ongoing PhD co-supervision – Anu Jääskeläinen, Antti Vaheri, 2002  … 
Ongoing PhD co-supervision – Paula Kinnunen, Antti Vaheri, 2005  … 
Ongoing PhD co-supervision – Jussi Hepojoki, Antti Vaheri, 2006  … 
Ongoing PhD cosupervision – Suvi Kuivanen, Antti Vaheri, 2006  … 
Ongoing PhD supervision – Hao Wang, Antti Vaheri, 2006  … 
Ongoing PhD supervision – Pertteli Salmenperä, Antti Vaheri, 2006  … 
Ongoing PhD co-supervision – Tomas Strandin, Antti Vaheri, 2007  … 
Ongoing PhD co-supervision – Anna Katz, Antti Vaheri, 2008  … 
Ongoing PhD co-supervision – Jussi Sane, Antti Vaheri, 2009  … 
Ongoing PhD co-supervision – Tuomas Rönnberg, Antti Vaheri, 2009  … 
PhD Thesis by Oskari Virtanen, Antti Vaheri, 2009 
PhD Thesis by Agne Alminaite, Antti Vaheri, 2010 
PhD Thesis by Anna Enzerink, Antti Vaheri, 2010 
PhD Thesis by Kati Räsänen, Antti Vaheri, 2010 
Aleksandr Pljusnin ,  
Supervision of Doctoral thesis, Aleksandr Pljusnin, 07.1999  05.2007, Finland 
Supervision of doctoral thesis, Aleksandr Pljusnin, 01.2000  03.2006, Sweden 
Supervision of Doctoral thesis, Aleksandr Pljusnin, 09.2004  12.2010, Finland 
Mikael Skurnik ,  
Supervision of PhD thesis of Saija Kiljunen, Mikael Skurnik, 1995  2005, Finland 
Supervision of PhD thesis of Jouni Issakainen, Mikael Skurnik, 1998  2009, Finland 
Supervision of PhD thesis of Elise Pinta, Mikael Skurnik, 1999  2010, Finland 
Supervision of PhD thesis of Marta Biedzka-Sarek, Mikael Skurnik, 2003  2008, Finland 
Supervision of PhD thesis of Saija Hallanvuo, Mikael Skurnik, 2003  2009, Finland 
Supervision of PhD thesis of Katarzyna Teresa Duda, Mikael Skurnik, 2005  2007, Poland 
Supervision of doctoral thesis, Mikael Skurnik, 01.01.2006  31.12.2006, Finland 
Supervision of doctoral thesis, Mikael Skurnik, 06.05.2007  31.12.2011, Poland 
Supervision of doctoral thesis, Mikael Skurnik, 31.07.2008, Poland 
Heidi Hyytiäinen ,  
Supervisor of Satu Olkkola's doctoral thesis, Heidi Hyytiäinen, 2008  …, Finland 
T. Sakari Jokiranta ,   
Supervision of PhD thesis (Ormsby), T. Sakari Jokiranta, 07.01.2000  31.12.2006, Australia 
Supervision of PhD thesis (Cheng), T. Sakari Jokiranta, 01.08.2001  31.12.2005, Finland 
Supervision of PhD thesis (T. Meri), T. Sakari Jokiranta, 01.01.2002  31.12.2005, Finland 
Mirja Puolakkainen ,  
Supervisor: Transcriptional analysis of persistent Chlamydia pneumoniae infection in vitro, Mirja Puolakkainen, 2000  2011 
Supervisor: CD8+ T cell response in experimental Chlamydia pneumoniae infection, Mirja Puolakkainen, 2005 
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Ongoing PhD supervision: Juha Korhonen, Mirja Puolakkainen, 2007  … 
Ongoing PhD supervision: Suvi Niemi, Mirja Puolakkainen, 2009  … 
Risto Renkonen ,  
Väitöskirjatyön ohjaus, Risto Renkonen, 2005 
Väitöskirjatyön ohjaus, Risto Renkonen, 2007 
Meneillään olevan väitöskirjatyön ohjaus, Risto Renkonen, 2009  … 
Väitöskirjatyön ohjaus, Risto Renkonen, 2009  … 
väitöskirjatyön ohjaus, Risto Renkonen, 2009 
Kalle Saksela ,  
Supervision of doctoral thesis, Kalle Saksela, 01.01.2000  23.04.2005, Finland 
Supervision of academic dissertation, Kalle Saksela, 2005 
Ongoing PhD supervision - Leena Ylösmäki, Kalle Saksela, 2007  … 
Ongoing PhD supervision - Erkko Ylösmäki, Kalle Saksela, 2008  … 
Ongoing PhD supervision - Sergio Lavilla-Alonso, Kalle Saksela, 2010  … 
Supervision of academic dissertation, Kalle Saksela, 2010 
Klaus Hedman ,  
Supervision of academic dissertation, Klaus Hedman, 2005, Finland 
Supervision of academic dissertation, Klaus Hedman, 2007, Finland 
Supervision of academic dissertation, Klaus Hedman, 2007, Finland 
Supervision of academic dissertation, Klaus Hedman, 2008, Finland 
Ongoing supervision of academic dissertation, Klaus Hedman, 29.10.2009  …, Finland 
Ongoing supervision of academic dissertation, Klaus Hedman, 03.09.2009  …, Finland 
Ongoing supervision of academic dissertation, Klaus Hedman, 04.11.2010  …, Finland 
Maria Söderlund-Venermo ,  
PhD supervision, Maria Söderlund-Venermo, 2005  2011, Finland 
PhD supervision, Maria Söderlund-Venermo, 2005  2011, Finland 
PhD Supervision, Maria Söderlund-Venermo, 2007, Finland 
PhD supervision, Maria Söderlund-Venermo, 2007  2011, Finland 
PhD Supervision, Maria Söderlund-Venermo, 2008, Finland 
Benita Westerlund-Wikström ,  
Flagellar secretion as a novel method to identify important peptides from a chromosomal library of <em>Staphylococcus aureus</em>, 
Benita Westerlund-Wikström, 2002  … 
Regulation, function and biogenesis of Mat fimbriae of meningitis-associated <em>Escherichia coli</em>, Benita Westerlund-Wikström, 
2007  … 
Timo Korhonen ,  
Mucosa-adherent lactobacilli: commensal and pathogenic characteristics, Timo Korhonen, 2005 
Functional studies of purified transmembrane proteases, omptins of Yersinia pestis and Salmonella enterica, Timo Korhonen, 2006, 
Brazil 
Outer membrane protease/adhesin PgtE of Salmonella enterica: role in Salmonella-host interaction, Timo Korhonen, 2007 
Surface proteins of Lactobacillus crispatus: adhesive properties and cell wall anchoring, Timo Korhonen, 2007 
Substrate selectivity and molecular adaptation in the outer membrane proteases of Yersinia pestis and Salmonella enterica, Timo 
Korhonen, 2010 
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Prizes and awards 
Antti Vaheri ,  
Medal of University of Helsinki, Antti Vaheri, 2008 
Eric K. Fernström Nordic Price, Antti Vaheri, 09.2010, Sweden 
Finnish Academy of Science and Letters Award, Antti Vaheri, 21.04.2010, Finland 
Zhilin Li ,  
Chancellor's Travel Grant 2010, Zhilin Li, 30.04.2010, Finland 
FEMS Meetiing Attendance Grant 2010, Zhilin Li, 23.09.2010, Netherlands 
Seppo Meri ,  
Membership in The Finnish Academy of Sciences, Seppo Meri, 2009  …, Finland 
Reviewer of the Year, Swedish Research Council, Seppo Meri, 2009, Sweden 
The Order of the White Rose, Knighthood First Class (SVR R1), Seppo Meri, 2009, Finland 
Tobias Freitag ,  
Oral Presentation Award at International Celiac Disease Symposium 2009, Tobias Freitag, 04.2009, Netherlands 
Derek Ho ,  
U.S Fulbright Student Award, Derek Ho, 01.09.2007  31.05.2008 
Risto Renkonen ,  
*Hgin yo hopeinen mitali, Risto Renkonen, 12.08.2010, Finland 
Duodecim Lauri Saxen mitali 2010, Risto Renkonen, 12.08.2010, Finland 
Medix palkinto 2010, Risto Renkonen, 06.09.2010, Finland 
Maria Söderlund-Venermo ,  
Award for outstanding review, Maria Söderlund-Venermo, 2008, United States 
Award for outstanding review, Maria Söderlund-Venermo, 2010, United States 
Laura Kakkola ,  
Pronze Medal from The Finnish Union of Experts in Science, Laura Kakkola, 03.10.2005, Finland 
Timo Antero Lehti ,  
Biotieteellisen tiedekunnan pro gradu –palkinto vuonna 2006, Timo Antero Lehti, 15.03.2007, Finland 
Editor of research journal 
Aleksandr Pljusnin ,  
Journal of Clinical Microbiology, Aleksandr Pljusnin, 01.01.2006  31.12.2011 
Journal of General Virology, Aleksandr Pljusnin, 01.01.2006  31.12.2011 
Scandinavian Journal of Infectious Diseases, Aleksandr Pljusnin, 01.01.2006  31.12.2011 
Virus Research, Aleksandr Pljusnin, 01.01.2006  31.12.2011 
Mikael Skurnik ,  
National Editor of APMIS, Mikael Skurnik, 2003  2011, Denmark 
APMIS, Mikael Skurnik, 01.01.2005  31.12.2005, Denmark 
APMIS, Mikael Skurnik, 01.01.2005  31.12.2005, Denmark 
Annals of Medicine, Mikael Skurnik, 01.01.2005  31.12.2005, Finland 
Applien and Environmental Microbiology, Mikael Skurnik, 01.01.2005  31.12.2005, United States 
Archivum Immunologiae et Therapiae Experimentalis, Mikael Skurnik, 01.01.2005  31.12.2005, Poland 
European Journal of Immunology, Mikael Skurnik, 01.01.2005  31.12.2005, Germany 
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FEMS Immunology and Microbiology, Mikael Skurnik, 01.01.2005  31.12.2005, United Kingdom 
FEMS Letters, Mikael Skurnik, 01.01.2005  31.12.2005, United Kingdom 
Infection and Immunity, Mikael Skurnik, 01.01.2005  31.12.2005, United States 
Journal of Bacteriology, Mikael Skurnik, 01.01.2005  31.12.2005, United States 
Journal of Bacteriology, Mikael Skurnik, 01.01.2005  31.12.2005, United States 
Journal of Endotoxin research, Mikael Skurnik, 01.01.2005  31.12.2005, United Kingdom 
Microbial Pathogenesis, Mikael Skurnik, 01.01.2005  31.12.2005, United States 
Molecular Microbiology, Mikael Skurnik, 01.01.2005  31.12.2005, United Kingdom 
Protein Expression ans Purification, Mikael Skurnik, 01.01.2005  31.12.2005, United Kingdom 
Trends in Microbiology, Mikael Skurnik, 01.01.2005  31.12.2005, United Kingdom 
journal of Clinical Microbiology, Mikael Skurnik, 01.01.2005  31.12.2005, United States 
APMIS, Mikael Skurnik, 01.01.2006  31.12.2006 
APMIS, Mikael Skurnik, 01.01.2006  31.12.2006 
Annals of Medicin, Mikael Skurnik, 01.01.2006  31.12.2006 
Annals of Medicin, Mikael Skurnik, 01.01.2006  31.12.2006 
Antimicrobial Agents and Chemotherapy, Mikael Skurnik, 01.01.2006  31.12.2006, United States 
Antimicrobial Agents and Chemotherapy, Mikael Skurnik, 01.01.2006  31.12.2006, United States 
Applied Microbiology and Biotechnology, Mikael Skurnik, 01.01.2006  31.12.2006, Germany 
Applied Microbiology and Biotechnology, Mikael Skurnik, 01.01.2006  31.12.2006, Germany 
Duodecim, Mikael Skurnik, 01.01.2006  31.12.2006 
Duodecim, Mikael Skurnik, 01.01.2006  31.12.2006 
EMBO Journal, Mikael Skurnik, 01.01.2006  31.12.2011, Germany 
EMBO Journal, Mikael Skurnik, 01.01.2006  31.12.2006, Germany 
EMBO Journal, Mikael Skurnik, 01.01.2006  31.12.2006, Germany 
FEBS Letters, Mikael Skurnik, 01.01.2006  31.12.2006, United Kingdom 
FEBS Letters, Mikael Skurnik, 01.01.2006  31.12.2006, United Kingdom 
FEMS Immunology and Microbiology, Mikael Skurnik, 01.01.2006  31.12.2006, United Kingdom 
FEMS Immunology and Microbiology, Mikael Skurnik, 01.01.2006  31.12.2006, United Kingdom 
Glycobiology, Mikael Skurnik, 01.01.2006  31.12.2006, United Kingdom 
Glycobiology, Mikael Skurnik, 01.01.2006  31.12.2006, United Kingdom 
Infection and Immunity, Mikael Skurnik, 01.01.2006  31.12.2006, United States 
Infection and Immunity, Mikael Skurnik, 01.01.2006  31.12.2006, United States 
Journal of Bacteriology, Mikael Skurnik, 01.01.2006  31.12.2006, United States 
Journal of Bacteriology, Mikael Skurnik, 01.01.2006  31.12.2006, United States 
Journal of Bacteriology, Mikael Skurnik, 01.01.2006  31.12.2006, United States 
Journal of Bacteriology, Mikael Skurnik, 01.01.2006  31.12.2006, United States 
Microbes &amp; Infection, Mikael Skurnik, 01.01.2006  31.12.2006, France 
Microbes &amp; Infection, Mikael Skurnik, 01.01.2006  31.12.2006, France 
Microbial Cell Factories, Mikael Skurnik, 01.01.2006  31.12.2006, United States 
Microbial Cell Factories, Mikael Skurnik, 01.01.2006  31.12.2006, United States 
Microbial Pathogenesis, Mikael Skurnik, 01.01.2006  31.12.2006, United States 
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Microbial Pathogenesis, Mikael Skurnik, 01.01.2006  31.12.2006, United States 
Trends in Microbiology, Mikael Skurnik, 01.01.2006  31.12.2006, United Kingdom 
Trends in Microbiology, Mikael Skurnik, 01.01.2006  31.12.2006, United Kingdom 
Seppo Meri ,  
Scandinavian Journal of Immunology, Seppo Meri, 13.02.2000  31.12.2011, Norway 
Scandinavian Journal of Immunology, Seppo Meri, 13.02.2000  31.12.2011, Norway 
Associate Editor, Journal of Immunology, Seppo Meri, 2001  2005, United States 
Associate Editor, Scand J Immunol, Seppo Meri, 2001  … 
Annals of Medicine, Seppo Meri, 13.02.2002  31.12.2011, Finland 
Annals of Medicine, Seppo Meri, 13.02.2002  31.12.2011, Finland 
Editor, Annals of Medicine, Seppo Meri, 2002  … 
Molecular Immunology, Seppo Meri, 13.02.2003  31.12.2011, Netherlands 
Molecular Immunology, Seppo Meri, 13.02.2003  31.12.2011, Netherlands 
BMC Immunology, Seppo Meri, 13.02.2004  31.12.2011, United Kingdom 
BMC Immunology, Seppo Meri, 13.02.2004  31.12.2011, United Kingdom 
Current Immunology Reviews, Seppo Meri, 13.02.2004  31.12.2011, United States 
Current Immunology Reviews, Seppo Meri, 13.02.2004  31.12.2011, United States 
Clinical and Experimental Immunology, Seppo Meri, 13.02.2005  31.12.2011, United Kingdom 
Clinical and Experimental Immunology, Seppo Meri, 13.02.2005  31.12.2011, United Kingdom 
Journal of Autoimmunity, Seppo Meri, 13.02.2006  31.12.2011, United States 
Journal of Autoimmunity, Seppo Meri, 13.02.2006  31.12.2011, United States 
Associate Editor, Duodecim, Seppo Meri, 2009  …, Finland 
Hanna Jarva ,  
Journal of Immunology, Hanna Jarva, 01.01.2005  31.12.2005 
Antti Lavikainen ,  
Parasitology, Antti Lavikainen, 01.01.2005  31.12.2005, United Kingdom 
T. Sakari Jokiranta ,   
APMIS, T. Sakari Jokiranta, 01.01.2005  31.12.2005, Denmark 
Scandinavian Journal of Immunology, T. Sakari Jokiranta, 01.01.2005  31.12.2005, Norway 
APMIS, T. Sakari Jokiranta, 01.01.2006  31.12.2006, Denmark 
Mol. Immunol., T. Sakari Jokiranta, 01.01.2006  31.12.2006, Netherlands 
Risto Renkonen ,  
Annals of Medicine, Risto Renkonen, 2000  2011 
Clinical Laboratory, Risto Renkonen, 2000  2011 
Glycoconjugate Journal, Risto Renkonen, 2000  2011 
Journal of Clinical Investigation, Risto Renkonen, 2000  2011 
Annals of Medicine, Risto Renkonen, 01.01.2005  31.12.2005, Finland 
Annals of Medicine, Risto Renkonen, 01.01.2005  31.12.2005, Finland 
Clinical Laboratory, Risto Renkonen, 01.01.2005  31.12.2005, Germany 
Clinical Laboratory, Risto Renkonen, 01.01.2005  31.12.2005, Germany 
FEBS Journal, Am J Pathol, Eurm J Immunol, Glycobiology, Scan J Immunol, Risto Renkonen, 01.01.2005  31.12.2005, United 
States 
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FEBS Journal, Am J Pathol, Eurm J Immunol, Glycobiology, Scan J Immunol, Risto Renkonen, 01.01.2005  31.12.2005, United 
States 
Glycoconjugate Journal, Risto Renkonen, 01.01.2005  31.12.2005, United States 
Glycoconjugate Journal, Risto Renkonen, 01.01.2005  31.12.2005, United States 
Annuals of Medicine, Risto Renkonen, 01.01.2006  31.12.2006, Finland 
Annuals of Medicine, Risto Renkonen, 01.01.2006  31.12.2006, Finland 
Clinical Laboratory, Risto Renkonen, 01.01.2006  31.12.2006, Germany 
Clinical Laboratory, Risto Renkonen, 01.01.2006  31.12.2006, Germany 
Duodecim, Risto Renkonen, 01.01.2006  31.12.2006, Finland 
Duodecim, Risto Renkonen, 01.01.2006  31.12.2006, Finland 
FEBS Journal, Risto Renkonen, 01.01.2006  31.12.2006 
FEBS Journal, Risto Renkonen, 01.01.2006  31.12.2006 
Glycobiology, Risto Renkonen, 01.01.2006  31.12.2006 
Glycobiology, Risto Renkonen, 01.01.2006  31.12.2006 
Glycoconjugate Journal, Risto Renkonen, 01.01.2006  31.12.2006, United States 
Glycoconjugate Journal, Risto Renkonen, 01.01.2006  31.12.2006, United States 
Glycoconjugate Journal, Risto Renkonen, 01.01.2010  31.12.2011 
Kalle Saksela ,  
Virology, Kalle Saksela, 2006  2013, United States 
Cell Communication and Signalling, Kalle Saksela, 2008  …, United Kingdom 
Timo Korhonen ,  
International Journal of Medical microbiology, Timo Korhonen, 01.01.2005  31.12.2005 
International Journal of Medical microbiology, Timo Korhonen, 01.01.2006  31.12.2006, Germany 
Innate Immunity, Timo Korhonen, 01.01.2008  31.12.2008, Germany 
International Journal of Medical Microbiology, Timo Korhonen, 01.01.2008  31.12.2008, Germany 
Peer review of manuscripts 
Mikael Skurnik ,  
Peer review for Microbial Pathogenesis, Mikael Skurnik, 1988  2011 
Peer review for APMIS, Mikael Skurnik, 1990  2011 
Peer review for Journal of Bacteriology, Mikael Skurnik, 1992  2011, United States 
Peer review for Infection and Immunity, Mikael Skurnik, 1993  2011, United States 
Peer review for Molecular Microbiology, Mikael Skurnik, 1993  2011 
Peer review for Trends in Microbiology, Mikael Skurnik, 1993  2006 
Editorial Board member of Journal of Bacteriology, Mikael Skurnik, 1998  2012, United States 
Peer review for Intl Journal of Medical Microbiology, Mikael Skurnik, 2000  2011 
Peer review for Microbiology-UK, Mikael Skurnik, 2000  2011 
Peer review for Annales of Medicin, Mikael Skurnik, 2001  2006 
Peer review for EMBO Journal, Mikael Skurnik, 2001  2009 
Peer review for Journal Antimicrobial Chemotherapy, Mikael Skurnik, 2001  2008 
Peer review for European Journal of Immunology, Mikael Skurnik, 2003  2005 
Peer review for FEMS Imm Med Microbiology, Mikael Skurnik, 2003  2011 
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Peer review for FEMS Microbiology Letters, Mikael Skurnik, 2003  2009 
Peer review for Clinical Microbiology and Infection, Mikael Skurnik, 2004  2008 
Peer review for FEMS Microbiology Reviews, Mikael Skurnik, 2004  2005 
Peer review for Appl Environmental Microbiology, Mikael Skurnik, 2005  2011, United States 
Peer review for Arch Immunol et Therapiae Exp, Mikael Skurnik, 2005  2007, Poland 
Peer review for Innate Immunity (former J Endotox Res), Mikael Skurnik, 2005  2011 
Peer review for Journal of Clinical Microbiology, Mikael Skurnik, 2005 
Peer review for Microbial Cell Factories, Mikael Skurnik, 2005  2006 
Peer review for Protein Expression and Purification, Mikael Skurnik, 2005 
Peer review for Antimicr Agents and Chemotherapy, Mikael Skurnik, 2006 
Peer review for Appl Microbiol and Biotechnology, Mikael Skurnik, 2006  2011 
Peer review for FEBS Letters, Mikael Skurnik, 2006 
Peer review for Glycobiology, Mikael Skurnik, 2006 
Peer review for Microbes and Infection, Mikael Skurnik, 2006  2008 
Peer review for Clinical Chemistry, Mikael Skurnik, 2007 
Peer review for Journal of Biological Chemistry, Mikael Skurnik, 2007 
Peer review for Microbial Biotechnology, Mikael Skurnik, 2007  2011 
Peer review for Proc Nat Acad Sci USA, Mikael Skurnik, 2007  2009 
Peer review for Scand J Immunol, Mikael Skurnik, 2007  2009 
Peer review for Vaccine, Mikael Skurnik, 2007  2009 
Editorial Board member of FEMS Immunology &amp; Medical Microbiology, Mikael Skurnik, 2008  2013, United States 
Peer review for American J Biomed Sci, Mikael Skurnik, 2008, United States 
Peer review for Archives of Virology, Mikael Skurnik, 2008  2011 
Peer review for Journal of Medical Microbiology, Mikael Skurnik, 2008  2009 
Peer review for Molecular Systems Biology, Mikael Skurnik, 2008 
Editorial board member of Innate Immunity (former J Endotox Res), Mikael Skurnik, 2009  2012 
Peer review for BMC Microbiology, Mikael Skurnik, 2009  2011 
Peer review for Cellular Microbiology, Mikael Skurnik, 2009 
Peer review for Critical Reviews in Microbiology, Mikael Skurnik, 2009  2011 
Peer review for Curr Opin in Investigational drugs, Mikael Skurnik, 2009 
Peer review for Environmental Microbiology, Mikael Skurnik, 2009  2011 
Peer review for Marine Drugs, Mikael Skurnik, 2009 
Peer review for Science, Mikael Skurnik, 2009 
Peer review for Biotechnology Advances, Mikael Skurnik, 2010  2011 
Peer review for FEMS Microbiology Ecology, Mikael Skurnik, 2010  2011 
Peer review for Plos One, Mikael Skurnik, 2010  2011 
Peer review for Plos pathogens, Mikael Skurnik, 2010  2011 
Hanna Jarva ,  
Scandinavian Journal of Immunology, Hanna Jarva, 2004  2011, Norway 
Journal of Immunology, Hanna Jarva, 2005  2011, United States 
APMIS, Hanna Jarva, 2006  2011 
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Clinical Infectious Diseases, Hanna Jarva, 2007  2011, United States 
Duodecim, Hanna Jarva, 2010  2011, Finland 
Tobias Freitag ,  
Annals of Medicine, Tobias Freitag, 2009  2011 
Molecular Immunology, Tobias Freitag, 2009  2011 
Scandinavian Journal of Immunology, Tobias Freitag, 2010  2011 
Derek Ho ,  
ad hoc reviewer, Scandinavian Journal of Immunology, Derek Ho, 2010  … 
Ayman Khattab ,  
Experimental Parasitology, Ayman Khattab, 2008  … 
Scandinavian Journal of Immunology, Ayman Khattab, 2010 
Mirja Puolakkainen ,  
Referee, Mirja Puolakkainen, 2005 
Referee, Mirja Puolakkainen, 2006 
Referee, Mirja Puolakkainen, 2007 
Referee, Mirja Puolakkainen, 2008 
Referee, Mirja Puolakkainen, 2009 
Referee, Mirja Puolakkainen, 2010 
Risto Renkonen ,  
American Journal of Pathology, Risto Renkonen, 1992  2011 
EMBO Journal, Risto Renkonen, 1992  2011 
European Journal of Immunology, Risto Renkonen, 1993  2011 
Journal of Immunology, Risto Renkonen, 1993  2011 
Journal of Clinical Investigation, Risto Renkonen, 1994  2011 
Glycobiology, Risto Renkonen, 1996  2011 
Allergy, Risto Renkonen, 1997  2011 
Kalle Saksela ,  
Peer reviewer of manuscripts, Kalle Saksela, 2005  … 
Klaus Hedman ,  
Peer reviewer of manuscript, Klaus Hedman, 2005, United States 
Peer reviewer of manuscript, Klaus Hedman, 2005, United States 
Peer reviewer of manuscript, Klaus Hedman, 2005, United States 
Peer reviewer of manuscript, Klaus Hedman, 2005, United States 
Peer reviewer of manuscript, Klaus Hedman, 2005, United States 
Peer reviewer of manuscript, Klaus Hedman, 2005, United States 
Peer reviewer of manuscript, Klaus Hedman, 2005, Netherlands 
Peer reviewer of manuscript, Klaus Hedman, 2005, United Kingdom 
Peer reviewer of manuscript, Klaus Hedman, 2006, United States 
Peer reviewer of manuscript, Klaus Hedman, 2006, United Kingdom 
Peer reviewer of manuscript, Klaus Hedman, 2006, United States 
Peer reviewer of manuscript, Klaus Hedman, 2006, United Kingdom 
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Peer reviewer of manuscript, Klaus Hedman, 2006, Netherlands 
Peer reviewer of manuscript, Klaus Hedman, 2006, United Kingdom 
Peer reviewer of manuscript, Klaus Hedman, 2006, United States 
Peer reviewer of manuscript, Klaus Hedman, 2007, United Kingdom 
Peer reviewer of manuscript, Klaus Hedman, 2007, United States 
Peer reviewer of manuscript, Klaus Hedman, 2007, United Kingdom 
Peer reviewer of manuscript, Klaus Hedman, 2007, United States 
Peer reviewer of manuscript, Klaus Hedman, 2007, United States 
Peer reviewer of manuscript, Klaus Hedman, 2008, United States 
Peer reviewer of manuscript, Klaus Hedman, 2008, United States 
Peer reviewer of manuscript, Klaus Hedman, 2008, United States 
Peer reviewer of manuscript, Klaus Hedman, 2008, United States 
Peer reviewer of manuscript, Klaus Hedman, 2008, United Kingdom 
Peer reviewer of manuscript, Klaus Hedman, 2008, United States 
Peer reviewer of manuscipt, Klaus Hedman, 2009, United States 
Peer reviewer of manuscript, Klaus Hedman, 2009, United States 
Peer reviewer of manuscript, Klaus Hedman, 2009, United States 
Peer reviewer of manuscript, Klaus Hedman, 2009, United Kingdom 
Peer reviewer of manuscript, Klaus Hedman, 2009, United States 
Peer reviewer of manuscript, Klaus Hedman, 2009, United Kingdom 
Peer reviewer of manuscript, Klaus Hedman, 2009, United States 
Peer reviewer of manuscript, Klaus Hedman, 2009, United States 
Peer reviewer of manuscript, Klaus Hedman, 2009, Sweden 
Peer reviewer of manuscript, Klaus Hedman, 2009, Netherlands 
Peer reviewer of manuscript, Klaus Hedman, 2009, United States 
Peer reviewer of manuscript, Klaus Hedman, 2009, Netherlands 
Peer reviewer of manuscript, Klaus Hedman, 2010, United States 
Peer reviewer of manuscript, Klaus Hedman, 2010, United States 
Peer reviewer of manuscript, Klaus Hedman, 2010, United States 
Peer reviewer of manuscript, Klaus Hedman, 2010, United States 
Peer reviewer of manuscript, Klaus Hedman, 2010, United States 
Peer reviewer of manuscript, Klaus Hedman, 2010, Netherlands 
Peer reviewer of manuscript, Klaus Hedman, 2010, Netherlands 
Peer reviewer of manuscript, Klaus Hedman, 2010, Netherlands 
Peer reviewer of manuscript, Klaus Hedman, 2010, Netherlands 
Peer reviewer of manuscript, Klaus Hedman, 2010, United States 
Peer reviewer of manuscript, Klaus Hedman, 2010, United States 
Maria Söderlund-Venermo ,  
J Med Virol, Maria Söderlund-Venermo, 2005 
J Virol Methods, Maria Söderlund-Venermo, 2005 
J Gen Virol, Maria Söderlund-Venermo, 2006 
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J Virol, Maria Söderlund-Venermo, 2006 
International Journal of Cancer, Maria Söderlund-Venermo, 2007 
J Med Virol, Maria Söderlund-Venermo, 2007 
Clinical Infectious Diseases, Maria Söderlund-Venermo, 2008 
J Gen Virol, Maria Söderlund-Venermo, 2008 
J Inf Dis, Maria Söderlund-Venermo, 2008 
Clinical Infectious Diseases, Maria Söderlund-Venermo, 2009 
Dermatology, Maria Söderlund-Venermo, 2009 
Emerging Infectious Diseases, Maria Söderlund-Venermo, 2009, United States 
Expert Opinion On Medical Diagnostics, Maria Söderlund-Venermo, 2009 
Expert Opinion On Medical Diagnostics, Maria Söderlund-Venermo, 2009 
Int J Infect Dis, Maria Söderlund-Venermo, 2009 
J Clin Virol, Maria Söderlund-Venermo, 2009 
J Infect Dis, Maria Söderlund-Venermo, 2009 
J Virol Methods, Maria Söderlund-Venermo, 2009 
Scan J Infect Dis, Maria Söderlund-Venermo, 2009 
Clinical Infectious Diseases, Maria Söderlund-Venermo, 2010, United States 
J Clin Virol, Maria Söderlund-Venermo, 2010 
J Infect Dis, Maria Söderlund-Venermo, 2010 
Pediatr Infect Dis J, Maria Söderlund-Venermo, 2010 
Reviews in Medical Virology, Maria Söderlund-Venermo, 2010 
Scan J Infect Dis, Maria Söderlund-Venermo, 2010 
Laura Kakkola ,  
Have peer reviewed several manuscripts, Laura Kakkola, 31.01.2005  … 
Benita Westerlund-Wikström ,  
Microbial Pathogenesis, Benita Westerlund-Wikström, 01.01.2001  31.12.2009 
Trends in Microbiology, Benita Westerlund-Wikström, 2005 
FEBS Letters, Benita Westerlund-Wikström, 2006  … 
FEMS Microbiology Letters, Benita Westerlund-Wikström, 2006  … 
Molecular Microbiology, Benita Westerlund-Wikström, 2006  … 
Microbiology, Benita Westerlund-Wikström, 2007  … 
Acta Crystallographica Section F, Structural Biology and Crystallization Communications, Benita Westerlund-Wikström, 2009  … 
Biochemistry, Benita Westerlund-Wikström, 2009 
Journal of Industrial Microbiology &amp; Biotechnology, Benita Westerlund-Wikström, 2009  … 
Timo Korhonen ,  
Reviewing, Timo Korhonen, 1995  … 
Faculty of 1000, Timo Korhonen, 2001  … 
Editor of communication journal 
T. Sakari Jokiranta ,   
Complement in Focus, T. Sakari Jokiranta, 01.08.2006  31.12.2013 
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Editor of series 
Seppo Meri ,  
Annals of Medicine, Associate Editor, Seppo Meri, 2003  … 
Klaus Hedman ,  
Editorial work, Klaus Hedman, 2010, Finland 
Timo Korhonen ,  
International Journal of Medical Microbiology, Timo Korhonen, 1999  …, Netherlands 
Innate Immunity, Timo Korhonen, 2008  … 
Assessment of candidates for academic posts 
Mikael Skurnik ,  
Evaluation of docent application in Cellular Microbiology at University of Helsinki, Mikael Skurnik, 05.01.2005, Finland 
Evaluation of docent application in Infection Research at University of Helsinki, Mikael Skurnik, 09.11.2005, Finland 
Evaluation of docent application in Molecular Biology at University of Umeå, Mikael Skurnik, 17.08.2005, Sweden 
Evaluation of docent application in Veterinary Bacteriology at University of Helsinki, Mikael Skurnik, 25.09.2005, Finland 
Evaluation of an associate professor for a promotion to full professor. University of Idaho, Mikael Skurnik, 03.11.2006, United States 
Recommendation for the promotion to a position equivalent to professor, Israel Institute for Biological Research, Mikael Skurnik, 
18.08.2006, Israel 
Evaluation of docent application in Molecular Virology at University of Helsinki, Mikael Skurnik, 17.03.2008, Finland 
Evaluation of Canada Research Chairs Program Tier 1 professor position application, Mikael Skurnik, 08.06.2009, Canada 
Evaluation of an Associate Professor to award tenure. University of Texas, Mikael Skurnik, 14.12.2009, United States 
Evaluation of docent application in Infection Research at University of Helsinki, Mikael Skurnik, 15.12.2009, Finland 
Benita Westerlund-Wikström ,  
Docentship (adjunct professorship) in molecular microbiology, Benita Westerlund-Wikström, 2007, Finland 
Docentship (adjunct professorship) in medical biochemistry, Benita Westerlund-Wikström, 2009, Finland 
Membership or other role in review committee 
Mikael Skurnik ,  
Evaluation of grant applications for Norwegian Research Council, Mikael Skurnik, 1995  2007, Norway 
International expert for INSERM, Mikael Skurnik, 2001  2008, France 
Member of the Norwegian Research Council Functional Genomics (FUGE) ad hoc peer review group, Mikael Skurnik, 2002  2006, 
Norway 
Evaluation of grant applications for Israel Binational Science Foundation, Mikael Skurnik, 2006, Israel 
Evaluation of grant applications for Slovak Research and Development Agency, Mikael Skurnik, 2007, Slovakia 
Evaluation of grant applications for Georgian National Science Foundation, Mikael Skurnik, 2008  2009, Georgia 
Evaluation of grant applications for Lithuanian State Science and Studies Foundation, Mikael Skurnik, 2008, Lithuania 
Evaluation of grant applications for Research Foundation Flanders, Mikael Skurnik, 2008, Netherlands 
Evaluation of grant applications, Mikael Skurnik, 2009, United Kingdom 
Evaluation of grant applications for Slovenian Research Agency, Mikael Skurnik, 2009  2010, Slovenia 
Evaluation of grant applications for The German-Israeli Foundation for Scientific Research and Development, Mikael Skurnik, 2009, 
Germany 
Evaluation panel member for grant applications, Mikael Skurnik, 27.05.2010  07.09.2010, Sweden 
Expert panel member for Swedish Research Council evaluation of MIMS, Mikael Skurnik, 22.11.2010  24.11.2010, Sweden 
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Benita Westerlund-Wikström ,  
FP6-2005-LIFESCIHEALTH-[6][7] Confronting the major communicable diseases linked to poverty, Benita Westerlund-Wikström, 
01.2006, Belgium 
Pool of Experts appointed by the University of Helsinki, Benita Westerlund-Wikström, 2006  2009, Finland 
The National Science Foundation, USA, Benita Westerlund-Wikström, 2006 
FP7-Health-2007A-2.3.2 Major Infectious Diseases (HIV/AIDS, malaria, tuberculosis), Benita Westerlund-Wikström, 05.2007, Belgium 
FP7-Health-2007A-2.3.2 Major Infectious Diseases (HIV/AIDS, malaria, tuberculosis), Benita Westerlund-Wikström, 09.2007, Belgium 
Swedish Research Council (Vetenskapsrådet), Benita Westerlund-Wikström, 2007, Sweden 
Swedish research council (Vetenskapsrådet), Benita Westerlund-Wikström, 2008, Sweden 
Faculty of 1000 post-publication peer review organization, Benita Westerlund-Wikström, 04.2010  … 
Swedish Research Council (Vetenskapsrådet), Benita Westerlund-Wikström, 2010, Sweden 
Timo Korhonen ,  
Genomik Plus, Timo Korhonen, 2006, Germany 
Medicine and Health, Timo Korhonen, 2008  2010, Sweden 
Medical Infection Genomics, Timo Korhonen, 2010, Germany 
Membership or other role in research network 
Risto Renkonen ,  
Consortium for Functional Glycomics, Risto Renkonen, 2001  2011, United States 
Glycoscience Graduate School (GGS), Risto Renkonen, 2006  2011, Finland 
Benita Westerlund-Wikström ,  
European Network of Excellence in EuroPathoGenomics EPG, Benita Westerlund-Wikström, 01.07.2005  30.06.2010 
EraNet PathoGenoMics I: Deciphering the intersection of commensal and extraintestinal E. coli, Benita Westerlund-Wikström, 
01.02.2007  31.01.2010 
Berryfermentation - New products and health promoting ingredients with berry fermentations, Benita Westerlund-Wikström, 01.01.2009 
 … 
SalWe- Strategic Center for Science, Technology and Innovation in Health and Well-being, Benita Westerlund-Wikström, 01.06.2010  
… 
Timo Korhonen ,  
Alfred Kordelin Foundation, Science section, Timo Korhonen, 2000  2009 
NoE Europathogenomics, Timo Korhonen, 2005  2010 
Membership or other role in national/international committee, council, board 
Antti Vaheri ,  
EMBO, Antti Vaheri, 01.01.1979  31.12.2011 
Aleksandr Pljusnin ,  
Expert in international committee, Aleksandr Pljusnin, 01.1997  12.2005 
Membership in international commitee, Aleksandr Pljusnin, 06.1999  … 
Membership in international committee, Aleksandr Pljusnin, 09.2000  … 
American Society of Microbiology, Aleksandr Pljusnin, 01.01.2006  31.12.2011, United States 
EU-expert panel, Aleksandr Pljusnin, 01.01.2006  31.12.2011 
Expert in international committee, Aleksandr Pljusnin, 01.2006  12.2011 
European SDC-expert panel, Aleksandr Pljusnin, 05.09.2007  31.12.2011 
Mikael Skurnik ,  
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Member of the committee on NBC matters, Mikael Skurnik, 2003  2006, Finland 
Member of the External Advisory Board of EU Era-Net project “PathoGenoMics”, Mikael Skurnik, 2004  2009, Belgium 
Member of the scientific advisory committee of docentship applications, Mikael Skurnik, 2004  2009, Finland 
American Society for Microbiology, Mikael Skurnik, 01.01.2005  31.12.2005, United States 
ERA NET Pathogenomics, Mikael Skurnik, 01.01.2005  31.12.2005 
Finnish Society for Immunology 1987, Mikael Skurnik, 01.01.2005  31.12.2005, Finland 
Finnish Society for Infectious Diseases, Mikael Skurnik, 01.01.2005  31.12.2005, Finland 
INSERM, Mikael Skurnik, 01.01.2005  31.12.2005, France 
International Endotoxin Society, Mikael Skurnik, 01.01.2005  31.12.2005 
Norges Forskningsråd, Mikael Skurnik, 01.01.2005  31.12.2005, Norway 
Societas Biochemica, Biophysica et Microbiologica Fenniae, Mikael Skurnik, 01.01.2005  31.12.2005, Finland 
4th Finnish Microbial Pathogensis Day, Mikael Skurnik, 20.09.2006  31.12.2006, Finland 
ERA NET Pathogenomics, 2006, tieteellisen neuvoston jäsen, Mikael Skurnik, 01.01.2006  31.12.2006 
INSERM, Mikael Skurnik, 01.01.2006  31.12.2006, France 
Microbes and Man Research program Final Symposium 2006 Unitas congress Center 14.-15.3.2006, Mikael Skurnik, 15.03.2006  
31.12.2006, Finland 
Norges Forskningsråd, 2006 Bioproduction-asiantuntijapaneeli, Mikael Skurnik, 01.01.2006  31.12.2006, Norway 
Norges Forskningsråd, 2006, FUGE platforms arviointikomitean jäsen, Mikael Skurnik, 01.01.2006  31.12.2006, Norway 
Norges Forskningsråd, 2006, FUGE platforms asiantuntijapaneelin jäsen, Mikael Skurnik, 01.01.2006  31.12.2006, Norway 
US-Israel Binational Science Foundation, 2006,, Mikael Skurnik, 01.01.2006  31.12.2006 
Member of the steering board of the M.D., Ph.D. program of Faculty of Medicine, University of Helsinki., Mikael Skurnik, 2007  2012, 
Finland 
Seppo Meri ,  
American Association of Immunologists, Seppo Meri, 19.05.2001  31.12.2011, United States 
American Association of Immunologists, Seppo Meri, 19.05.2001  31.12.2011, United States 
Board of the Scandinavian Society for Immunology, Seppo Meri, 2001  2011, Sweden 
SCANDINAVIAN SOCIETY FOR IMMUNOLOGY, Seppo Meri, 01.01.2001  13.06.2007, Finland 
SCANDINAVIAN SOCIETY FOR IMMUNOLOGY, Seppo Meri, 01.01.2001  13.06.2007, Finland 
International Complement Society , Seppo Meri, 06.09.2003  09.09.2006, United States 
International Complement Society , Seppo Meri, 06.09.2003  09.09.2006, United States 
Foundation for Finnish Veterinary Medicine, Seppo Meri, 01.01.2005  31.12.2011, Finland 
Foundation for Finnish Veterinary Medicine, Seppo Meri, 01.01.2005  31.12.2011, Finland 
INTERNATIONAL UNION OF IMMUNOLOGICAL SOCIETIES, Seppo Meri, 19.05.2005  31.12.2011, Switzerland 
INTERNATIONAL UNION OF IMMUNOLOGICAL SOCIETIES, Seppo Meri, 19.05.2005  31.12.2011, Switzerland 
Suomen Immunologiayhdistys/ 1st Annual Finnish Immunology Meeting, Seppo Meri, 19.05.2005  20.05.2005, Finland 
Suomen Immunologiayhdistys/ 1st Annual Finnish Immunology Meeting, Seppo Meri, 19.05.2005  20.05.2005, Finland 
STEERING COMMITTEE OF THE PANEUROPEAN CONGRESS OF IMMUNOLOGY, Seppo Meri, 06.09.2006  09.09.2006, France 
STEERING COMMITTEE OF THE PANEUROPEAN CONGRESS OF IMMUNOLOGY, Seppo Meri, 06.09.2006  09.09.2006, France 
Secretary General of IUIS, Seppo Meri, 2010  2013 
Hanna Jarva ,  
Scandinavian society for Immunology, Hanna Jarva, 01.04.1997  31.12.2011 
Suomen Immunologiayhdistys, Hanna Jarva, 01.04.1997  31.12.2011, Finland 
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Infektiotautien tutkimusyhdistys, Hanna Jarva, 15.11.1999  31.12.2011, Finland 
Societas biochemica, biophysica et microbiologica Fenniae, Hanna Jarva, 15.04.1999  31.12.2011, Finland 
David Livingstone -seura, Hanna Jarva, 15.11.2002  31.12.2011, Finland 
Scandinavian Society for Immunology, Hanna Jarva, 15.06.2007  31.12.2011 
Treasurer, Hanna Jarva, 2007  2013 
Dosenttitoimikunta, Hanna Jarva, 2010  2012, Finland 
T. Sakari Jokiranta ,   
European Complement Network, T. Sakari Jokiranta, 05.08.2003  25.08.2009, Ecuador 
European Complement Network, T. Sakari Jokiranta, 01.01.2005  31.12.2005 
European Complement Network, T. Sakari Jokiranta, 01.01.2006  31.12.2006 
Infektiotautien tutkimusyhdistys, T. Sakari Jokiranta, 15.04.2008  …, Finland 
International Complement Standardization Committee, T. Sakari Jokiranta, 15.10.2008  … 
EASI työryhmä, T. Sakari Jokiranta, 14.09.2009  …, Finland 
European Complement Network, T. Sakari Jokiranta, 25.08.2009  …, Ecuador 
Kliinisen mikrobiologian erikoislääkärikoulutuksen selvitysryhmä, T. Sakari Jokiranta, 07.05.2009  …, Finland 
HY Lääk tdk:n YVV-toimikunta, T. Sakari Jokiranta, 2010  …, Finland 
HY lääk tdk Laatutoimikunta, T. Sakari Jokiranta, 2010  …, Finland 
Mirja Puolakkainen ,  
American Society for Microbiology, Mirja Puolakkainen, 1992  …, United States 
HUS-piirin Koordinoiva Eettinen toimikunta, Mirja Puolakkainen, 2005  … 
European Society for Chlamydial Research, Mirja Puolakkainen, 2006  … 
Kliiniset Mikrobiologit ry, Mirja Puolakkainen, 2006  … 
Suomen Kliiniset Mikrobiologit, Mirja Puolakkainen, 2006  … 
Update on current care guidelines: Diagnosis and treatment of sexually transmitted infections, Mirja Puolakkainen, 2009  2010 
Risto Renkonen ,  
Suomen Glyco-jaos, Risto Renkonen, 01.01.2005  31.12.2005, Finland 
Suomen Glyco-jaos, Risto Renkonen, 01.01.2005  31.12.2005, Finland 
Suomen immunologia yhdistys, Risto Renkonen, 01.01.2005  31.12.2005, Finland 
Suomen immunologia yhdistys, Risto Renkonen, 01.01.2005  31.12.2005, Finland 
Kalle Saksela ,  
Finnish Academy of Science and Letters, Kalle Saksela, 01.01.2003  31.12.2011, Finland 
Finnish Academy of Science and Letters, Kalle Saksela, 01.01.2003  31.12.2011, Finland 
Klaus Hedman ,  
International scientific committee membership, Klaus Hedman, 1990  … 
Authorized representative, Klaus Hedman, 1996  …, Finland 
Council membership, Klaus Hedman, 2002  … 
Council membership, Klaus Hedman, 2006  …, Finland 
Grant committee membership, Klaus Hedman, 2008  2010, Finland 
Grant committee membership, Klaus Hedman, 2009  … 
Grant committee membership, Klaus Hedman, 2009  … 
International editorial board membership, Klaus Hedman, 2009  … 
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Maria Söderlund-Venermo ,  
European Society for Clinical Virology, Maria Söderlund-Venermo, 2000  2011 
Suomen Sairaalamikrobiologit ry, Maria Söderlund-Venermo, 2002  2011, Finland 
The Finnish Society for the Study of Infectious Diseases, Maria Söderlund-Venermo, 03.05.2006  31.12.2011, Finland 
The Finnish Society for the Study of Infectious Diseases, Maria Söderlund-Venermo, 03.04.2007  31.12.2010, Finland 
Laura Kakkola ,  
Member of The Association of Finnish Cell Biologists, Laura Kakkola, 1997  … 
Member of European Society for Clinical Virology, Laura Kakkola, 1999  … 
Member of The Finnish Society for Study of Infectious Diseases, Laura Kakkola, 1999  … 
Member of The Finnish Union of Experts in Science, Division of medical cell biologists, Laura Kakkola, 1999  … 
Member of the Circovirus Study Group, Laura Kakkola, 13.02.2006  … 
Member of The Helsinki Association of Women in Research, Laura Kakkola, 2007  … 
Benita Westerlund-Wikström ,  
American Society for Microbiology, Benita Westerlund-Wikström, 1987  … 
Federation of European Microbiological Societies (FEMS), Benita Westerlund-Wikström, 1988  … 
Societas Biochemica Biophysica et Microbiologica Fenniae, Benita Westerlund-Wikström, 1988  … 
Microbiology research programme of the Viikki Research Group Organization in Molecular Biosciences, Benita Westerlund-Wikström, 
11.2001  … 
FEMS Council, Benita Westerlund-Wikström, 05.2002  … 
3rd FEMS Congress of European Microbiologists, Benita Westerlund-Wikström, 09.2006  06.2009 
Committee for Advancement of Quality assurance, Faculty of Biosciences, University of Helsinki, Benita Westerlund-Wikström, 
01.01.2006  30.11.2007 
FEMS Grants board, Benita Westerlund-Wikström, 09.2006  08.2009 
Membership or other role in public Finnish or international organization 
Mikael Skurnik ,  
Member in Societas Biochemica, Biophysica et Microbiologica Fenniae, Mikael Skurnik, 1975  2011, Finland 
Member in Finnish Society for Immunology, Mikael Skurnik, 1987  2011, Finland 
Member in Finnish Society for Infectious Diseases, Mikael Skurnik, 1987  2011, Finland 
Member in American Society for Microbiology, Mikael Skurnik, 1991  2011, United States 
Member in International Endotoxin and Innate Immunity Society, Mikael Skurnik, 1994  2011, United States 
Board member in Societas Biochemica, Biophysica et Microbiologica Fenniae, Mikael Skurnik, 2005  2011, Finland 
STM NBC-jaosto, Mikael Skurnik, 01.01.2005  31.12.2005, Finland 
Sos ja Terv Ministeriö, NBC-jaosto, Mikael Skurnik, 01.01.2006  31.12.2006, Finland 
Tobias Freitag ,  
Membership, Tobias Freitag, 01.02.2008  2011, United States 
Membership, Tobias Freitag, 01.01.2009  2011, Finland 
T. Sakari Jokiranta ,   
HUSLAB, sivuvirkainen erikoislääkäri, T. Sakari Jokiranta, 01.01.2005  31.12.2005, Finland 
Labquality oy, asiantuntija parasitologisen diagnostiikan laaduntarkkailussa, T. Sakari Jokiranta, 01.01.2005  31.12.2005, Finland 
Päätäiasiantuntijaryhmä (Suomi), T. Sakari Jokiranta, 31.08.2006  31.12.2006, Finland 
Risto Renkonen ,  
HUS, EVO-tutkimustoimikunta, Risto Renkonen, 01.01.2003  … 
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HUSLAB johtoryhmä, Risto Renkonen, 01.01.2009  … 
Tutkimuksesta vastaava varadekaani, Risto Renkonen, 2009, Finland 
Yliopistotoimikunta (HY ja HUS), Risto Renkonen, 30.06.2009  … 
HUSLAB uudisrakennustoimikunta, Risto Renkonen, 01.01.2010  … 
HY, FIMM, Risto Renkonen, 2010  … 
HY, Kirjaston johtokunta, Risto Renkonen, 2010  … 
HY, Neurotieteen tutkimuskeskus, johtokunta, Risto Renkonen, 01.01.2010  … 
HY, Terkko Kirjaston neuvottelukunta, Risto Renkonen, 2010  … 
HY, Tila- ja kiinteistökeskus, Risto Renkonen, 2010  …, Finland 
Helsingin yliopiston kollegion jäsen, Risto Renkonen, 02.01.2010  …, Finland 
Lääkärikoulutuksen alueellinen neuvottelutoimikunta, Risto Renkonen, 2010  … 
Meilahden Biopankin johtoryhmä, Risto Renkonen, 2010  … 
Kalle Saksela ,  
Board member of Helsinki Biomedical Graduate School, Kalle Saksela, 2006  … 
Vice member of Board of Biomedicum Helsinki, Kalle Saksela, 2006  … 
Vice member of Board of Terkko - National Library of Health Sciences, Kalle Saksela, 2006  2009 
Board member of Biocentrum Helsinki, Kalle Saksela, 2007  2010 
Board member of Research Council of Helsinki University Faculty of Medicine, Kalle Saksela, 2007  2009 
Board of Haartman Institute, Kalle Saksela, 2007  … 
Chairman of Doctoral thesis committee of Helsinki University Faculty of Medicine, Kalle Saksela, 2007  2009 
Vice director of Biocentrum Helsinki, Kalle Saksela, 01.07.2007  31.12.2010 
Vice member of Faculty Council of Helsinki University Faculty of Medicine, Kalle Saksela, 2007  … 
Board member of Committee for International Affairs of Faculty of Medicine, Kalle Saksela, 2008  … 
Director of Biocentrum Helsinki, Kalle Saksela, 01.01.2009  30.06.2009 
Member of Helsinki University Election Collegium, Kalle Saksela, 2009  … 
Board member of Institute of Biotechnology, Kalle Saksela, 2010  … 
Vice director of Haartman Institute, Kalle Saksela, 2010  … 
Vice member of Board of Institute for Molecular Medicine Finland, Kalle Saksela, 2010  … 
Benita Westerlund-Wikström ,  
Committee for Advancement of Research and Postgraduate Degrees, Faculty of Biological and Environmental Sciences, University of 
Helsinki, Benita Westerlund-Wikström, 05.2004  … 
Timo Korhonen ,  
GenoMik-Plus Programme: Functional Genome Research on Bacteria Relevant for Agriculture, Environment, and Biotechnology; 
German Ministry for Education and Research, Timo Korhonen, 01.01.2006  31.12.2006, Germany 
Membership or other role of body in private company/organisation 
Mikael Skurnik ,  
Biochemica, biophysica et Microbiologica Fenniae,, Mikael Skurnik, 01.01.2006  31.12.2006, Finland 
Seppo Meri ,  
Duodecim Society, Seppo Meri, 13.02.1984  31.12.2011, Finland 
Duodecim Society, Seppo Meri, 13.02.1984  31.12.2011, Finland 
T. Sakari Jokiranta ,   
David Livingstone seura (Finnish Society for International Health), T. Sakari Jokiranta, 01.01.2005  31.12.2005, Finland 
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David Livingstone Seura, T. Sakari Jokiranta, 01.01.2006  15.04.2006, Finland 
Risto Renkonen ,  
HUS ohjausryhmä, Risto Renkonen, 2009  … 
Duodecim, Risto Renkonen, 2010  2011 
Sigrid Juseliuksen Säätiö, Risto Renkonen, 01.06.2010  … 
Kalle Saksela ,  
Chief Scientific Officer and board member, Next Biomed Oy, Kalle Saksela, 2007  … 
Maria Söderlund-Venermo ,  
Daghemsföreningen Biet ry, Maria Söderlund-Venermo, 01.01.2003  31.12.2008, Finland 
Daghemsföreningen Biet ry, Maria Söderlund-Venermo, 01.01.2007  01.02.2008, Finland 
Participation in interview for written media 
Aleksandr Pljusnin ,  
HUSAR-lehti, Aleksandr Pljusnin, 01.11.2006, Finland 
Mikael Skurnik ,  
Haastattelu Mediuutisissa., Mikael Skurnik, 20.05.2005, Finland 
Mediuutiset, Mikael Skurnik, 2006, Finland 
Suomen Lääkärilehti, Mikael Skurnik, 2006, Finland 
HUSARI 1 / 2007, Mikael Skurnik, 01.04.2007, Finland 
Seppo Meri ,  
Artikel i Åbo Underrättelser., Seppo Meri, 21.05.2005, Finland 
Haastattelu: Mediuutiset 3.6.2005, Seppo Meri, 03.06.2005, Finland 
Lehtiartikkeli Maaseudun Tulevaisuudessa, Seppo Meri, 23.05.2005, Finland 
Lehtiartikkeli Mediuutiset 11/2005, Seppo Meri, 01.05.2005, Finland 
Lehtiartikkeli Tampereen Aamulehdessä, Seppo Meri, 21.05.2005, Finland 
National Post, Seppo Meri, 2005, Finland 
Suomen Immunologiayhdistyksen Juhlasymposium, Turku 19.-20.5.2005, Seppo Meri, 19.05.2005, Finland 
Turun Sanomat verkkolehti, Seppo Meri, 21.05.2005, Finland 
lehtiartikkeli Turun Sanomat, Seppo Meri, 21.05.2005, Finland 
Artikel i Åbo Underrättelser., Seppo Meri, 04.07.2006  31.12.2011, Finland 
Haastattelu: Mediuutiset 3.6.2005, Seppo Meri, 04.07.2006  31.12.2011, Finland 
Lehtiartikkeli Maaseudun Tulevaisuudessa, Seppo Meri, 04.07.2006  31.12.2011, Finland 
Lehtiartikkeli Mediuutiset 11/2005, Seppo Meri, 04.07.2006  31.12.2011, Finland 
Lehtiartikkeli Tampereen Aamulehdessä, Seppo Meri, 04.07.2006  31.12.2011, Finland 
National Post, Seppo Meri, 04.07.2006  31.12.2011, Finland 
Suomen Immunologiayhdistyksen Juhlasymposium, Turku 19.-20.5.2005, Seppo Meri, 04.07.2006  31.12.2011, Finland 
Turun Sanomat verkkolehti, Seppo Meri, 04.07.2006  31.12.2011, Finland 
YLE Internytt, Seppo Meri, 04.07.2006  31.12.2011, Finland 
lehtiartikkeli Turun Sanomat, Seppo Meri, 04.07.2006  31.12.2011, Finland 
T. Sakari Jokiranta ,   
Kirja Evidence Based Medicine (kustantajana Wiley&amp;Sons), T. Sakari Jokiranta, 2005, Finland 
Kirja Lääkärin käsikirja 2006 (kustantajana Duodecim), T. Sakari Jokiranta, 15.01.2005, Finland 
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Laaduntarkkailupäivät, T. Sakari Jokiranta, 10.02.2006, Finland 
Matkailulääketieteen kurssi, T. Sakari Jokiranta, 20.04.2006, Finland 
Kihomatoja on taas liikkeellä, Helsingin Sanomat 12.1.2009, T. Sakari Jokiranta, 12.01.2009, Finland 
Lapamatoa metsästämässä, T. Sakari Jokiranta, 08.02.2010, Finland 
Mirja Puolakkainen ,  
Kuukauden mikrobi, Mirja Puolakkainen, 2007 
Participation in radio programme 
Seppo Meri ,  
Radio Vega haastattelu, Seppo Meri, 23.05.2005  31.12.2011, Finland 
Radio Vega, haastattelu, Seppo Meri, 20.05.2005  31.12.2011, Finland 
YLE Turun Radio Uutiset, Seppo Meri, 20.05.2005  31.12.2011, Finland 
Yleisradion haastattelu, Seppo Meri, 29.04.2005  31.12.2011, Finland 
Radio Vega haastattelu, Seppo Meri, 04.07.2006  31.12.2011, Finland 
Radio Vega, haastattelu, Seppo Meri, 04.07.2006  31.12.2011, Finland 
YLE Turun Radio Uutiset, Seppo Meri, 04.07.2006  31.12.2011, Finland 
Yleisradion haastattelu, Seppo Meri, 04.07.2006  31.12.2011, Finland 
Risto Renkonen ,  
haastattelu radio-ohjelmassa v. 2005-2010, Risto Renkonen, 2005  2010 
Participation in TV programme 
Seppo Meri ,  
TV-nytt haastattelu, Seppo Meri, 20.05.2005  31.12.2011, Finland 
YLE Internytt, Seppo Meri, 20.05.2005  31.12.2011, Finland 
TV-nytt haastattelu, Seppo Meri, 04.07.2006  31.12.2011, Finland 
T. Sakari Jokiranta ,   
Nelosen uutiset, T. Sakari Jokiranta, 05.11.2009, Finland 
Tutkiva juttu: loiset, T. Sakari Jokiranta, 05.11.2009, Finland 
Risto Renkonen ,  
TV-HAASTATTELU, Risto Renkonen, 2005  2010 
TV-ohjelma MTV3:lla, Risto Renkonen, 02.06.2006  31.12.2011, Finland 
TV-ohjelma MTV3:lla, Risto Renkonen, 04.07.2006  31.12.2011, Finland 
Kalle Saksela ,  
Tv-uutiset (News), Kalle Saksela, 21.05.2010 
Maria Söderlund-Venermo ,  
Prisma Studio TV science program, Maria Söderlund-Venermo, 09.01.2008, Finland 
Participation in interview for web based media 
Risto Renkonen ,  
Haastattelu verkkomediassa, Risto Renkonen, 2005  2010 
Kalle Saksela ,  
Interview, Yle, Kalle Saksela, 2010 
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Web of Science(WoS)-based bibliometrics of the RC’s publications data 1.1.2005-31.12.2010  
by CWTS, Leiden University, the Netherlands 
Research Group: Meri S 
Basic statistics 
Number of publications (P) 411 
Number of citations (TCS) 2,850 
Number of citations per publication (MCS)   6.99 
Percentage of uncited publications 24% 
Field-normalized number of citations per publication (MNCS)    .97 
Field-normalized average journal impact (MNJS)   1.13 
Field-normalized proportion highly cited publications (top 10%)    .94 
Internal coverage    .91 
 
Trend analyses 
 
MNCS 
 
THCP10 
 
MNJS 
Collaboration 
 
Performance (MNCS) by collaboration type 
 
 
 
INTERNATIONAL EVALUATION OF RESEARCH AND DOCTORAL TRAINING  
AT THE UNIVERSITY OF HELSINKI  
Web of Science(WoS)-based bibliometrics of the RC’s publications data 1.1.2005-31.12.2010  
by CWTS, Leiden University, the Netherlands 
Research profile 
 
 
  
 
University of Helsinki 
Administrative Publications 80/36 
Evaluations 
 
ISBN 978-952-10-7456-1 (PDF) 
ISSN 1795-5513 (Online) 
 
Internet address: 
http://www.helsinki.fi/julkaisut/aineisto/rc_evaluation2012/hallinnon_julkaisuja_80_36_2012.pdf 
